Sample analysis apparatus and control method thereof

Abstract

The invention is applicable to the field of in vitro diagnostic equipment, and discloses sample analysis equipment and a control method of the sample analysis equipment, the sample analysis equipment comprises a sample measuring device, a camera device, a display device and a control device, the display device is used for displaying a first interface, and the control device is used for controlling the camera device. The first interface is used for displaying a first target image obtained by shooting the sample container according to the camera device; and displaying a second target image obtained by shooting the sample container according to the camera device, information used for representing a hematocrit detection result of the blood sample, information used for representing a clot detection result of the blood sample, and information used for representing a liquid amount detection result of the blood sample. The information is at least one of information for representing a hemolysis detection result of the blood sample, information for representing a jaundice detection result of the blood sample, and information for representing a lipid detection result of the blood sample. According to the invention, the efficiency and intuition of blood sample quality auditing are improved.

Description

Technical Field

[0001] The present invention relates to the field of in vitro diagnostic equipment, and in particular to a sample analysis device and a control method for the sample analysis device. Background Art

[0002] A sample analysis device provided by the related technology is used to perform coagulation detection on a blood sample. Before the sample analysis device performs coagulation detection on the blood sample, if there is a quality problem with the blood sample, the coagulation detection result of the blood sample may be inaccurate. For example, if at least one of the following problems exists in the blood sample before the coagulation detection, the coagulation detection result of the blood sample may be inaccurate: the HIL of the blood sample (HIL includes hemolysis index H, icterus index I, and lipemia index L) exceeds the anti-interference ability of the detection item; the total liquid volume of the blood sample is less than the liquid volume threshold; the HCT (hematocrit) of the blood sample is greater than the first hematocrit threshold; the HCT of the blood sample is less than the second hematocrit threshold; there is a clot in the blood sample. Therefore, when verifying whether the coagulation detection result of the blood sample is accurate, it is necessary to combine the quality detection information of the blood sample such as HIL, total liquid volume, HCT, and whether there is a clot as a reference.

[0003] In the related art, the quality inspection information of the blood sample, such as HIL, total liquid volume, HCT, whether there is a clot, etc., is obtained by different detection methods, and each quality inspection information obtained by these different detection methods will be stored in different locations. In this way, if the operator needs to view the quality inspection information of a blood sample, such as HIL, total liquid volume, HCT, clot, etc., it is necessary to search for them one by one through multiple different channels, which is very troublesome and seriously affects the efficiency of the blood sample quality review. In addition, in the related art, when searching for the quality inspection information of the blood sample, such as HIL, total liquid volume, HCT, clot, etc., only the final quality inspection result can be seen, but the sample image cannot be seen. This is not conducive to the operator to intuitively check whether these quality inspection results are correct, especially the operator's review of the clot detection information. Summary of the invention

[0004] The first object of the present invention is to provide a sample analysis device, which aims to solve the technical problem of low efficiency in blood sample quality audit in the related art.

[0005] To achieve the above object, the present invention provides a solution: a sample analysis device, comprising:

[0006] A sample measuring device, the sample measuring device is used to draw at least part of the upper layer liquid from a sample container loaded with a blood sample and after the blood sample is centrifuged and separated into an upper layer liquid, a middle layer liquid, and a lower layer liquid, and distribute the upper layer liquid to a reaction container for measurement, wherein the middle layer liquid at least contains platelets and / or leukocytes;

[0007] a camera device, the camera device being used to photograph the sample container loaded with the blood sample and after the blood sample is centrifuged and separated into the upper layer liquid, the middle layer liquid, and the lower layer liquid before the sample measuring device draws the upper layer liquid from the sample container;

[0008] a display device, the display device being used to display a first interface, the first interface being used to display a first target image obtained by photographing the sample container by the camera device, and displaying at least one of a second target image obtained by photographing the sample container by the camera device, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0009] A control device, the control device being configured to: in response to a trigger instruction, control the display device to display the first interface;

[0010] Wherein, there is a boundary liquid surface or boundary liquid layer between the intermediate layer liquid and the upper layer liquid;

[0011] The first target image at least includes an image showing the interface liquid surface or the interface liquid layer in a two-dimensional form and / or a three-dimensional form;

[0012] The second target image at least includes an image showing the entire height of at least one side of the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the entire blood sample in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing the liquid surface of the upper liquid layer, the liquid surface of the middle liquid layer, and the liquid surface of the lower liquid layer in the sample container, or at least includes an image showing at least one side of the entire upper liquid layer, the entire middle liquid layer, and the entire lower liquid layer in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the bottom, middle part, and top of the sample container in a two-dimensional and / or three-dimensional form.

[0013] As an implementation manner, the first interface is used to display at least the first target image and the second target image;

[0014] Alternatively, the first interface is used to display at least the first target image and information used to characterize the clot detection result of the blood sample in the sample container;

[0015] Alternatively, the first interface is used to display at least the first target image and information used to characterize a hematocrit test result of the blood sample in the sample container.

[0016] As an embodiment, the first interface is used to display the first target image, and display at least two of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0017] Preferably, the first interface is used to display the first target image and the second target image, and to display at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0018] Alternatively, the first interface is used to display the first target image and information for characterizing a clot detection result of the blood sample in the sample container, and display at least one of information for characterizing a hematocrit detection result of the blood sample in the sample container, information for characterizing a liquid volume detection result of the blood sample in the sample container, information for characterizing a hemolysis detection result of the blood sample in the sample container, information for characterizing a jaundice detection result of the blood sample in the sample container, and information for characterizing a lipemia detection result of the blood sample in the sample container;

[0019] Alternatively, the first interface is used to display the first target image and information for characterizing a hematocrit test result of the blood sample in the sample container, and to display at least one of information for characterizing a liquid volume test result of the blood sample in the sample container, information for characterizing a hemolysis test result of the blood sample in the sample container, information for characterizing a jaundice test result of the blood sample in the sample container, and information for characterizing a lipemia test result of the blood sample in the sample container.

[0020] As an embodiment, the first interface is used to display the first target image, and display at least three of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0021] Preferably, the first interface is used to display at least the first target image, the second target image, information for characterizing a hematocrit test result of the blood sample in the sample container, and information for characterizing a clot test result of the blood sample in the sample container;

[0022] Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize a clot detection result of the blood sample in the sample container, and information used to characterize a liquid volume detection result of the blood sample in the sample container;

[0023] Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, and information used to characterize the liquid volume test result of the blood sample in the sample container;

[0024] Alternatively, the first interface is used to display at least the first target image, information for characterizing a clot detection result of the blood sample in the sample container, information for characterizing a hematocrit detection result of the blood sample in the sample container, and information for characterizing a liquid volume detection result of the blood sample in the sample container;

[0025] Alternatively, the first interface is at least used to display the first target image, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

[0026] As an embodiment, the first interface is used to display the first target image, and at least four of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0027] Preferably, the first interface is used to display at least the first target image, the second target image, information for characterizing a hematocrit test result of the blood sample in the sample container, information for characterizing a clot test result of the blood sample in the sample container, and information for characterizing a liquid volume test result of the blood sample in the sample container;

[0028] Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container; or,

[0029] Alternatively, the first interface is used to display the first target image, information for characterizing a hematocrit test result of the blood sample in the sample container, information for characterizing a clot test result of the blood sample in the sample container, information for characterizing a liquid volume test result of the blood sample in the sample container, information for characterizing a hemolysis test result of the blood sample in the sample container, information for characterizing a jaundice test result of the blood sample in the sample container, and information for characterizing a lipemia test result of the blood sample in the sample container;

[0030] Alternatively, the first interface is used to display the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

[0031] As an implementation manner, the first interface includes:

[0032] A first display area, wherein the first display area is used to display the first target image;

[0033] a second display area, wherein the second display area is used to display the second target image;

[0034] a third display area, the third display area being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0035] Preferably, the first display area, the second display area and the third display area are distributed in the following manner:

[0036] The first display area, the second display area and the third display area are arranged and distributed along a first direction;

[0037] The first display area, the second display area and the third display area are arranged and distributed along a second direction;

[0038] Two of the first display area, the second display area and the third display area are arranged and distributed along a first direction, and an area formed by the two together with another one is arranged and distributed along a second direction;

[0039] Two of the first display area, the second display area and the third display area are arranged and distributed along the second direction, and the area formed by the two together with the other one is arranged and distributed along the first direction;

[0040] The first direction and the second direction are perpendicular to each other.

[0041] As an implementation manner, the first display area, the second display area and the third display area are arranged and distributed along the first direction, and the second display area is located between the first display area and the third display area;

[0042] And / or, the third display area is used to display information characterizing the hematocrit test result of the blood sample in the sample container, information characterizing the clot test result of the blood sample in the sample container, information characterizing the liquid volume test result of the blood sample in the sample container, information characterizing the hemolysis test result of the blood sample in the sample container, information characterizing the jaundice test result of the blood sample in the sample container, and information characterizing the lipemia test result of the blood sample in the sample container.

[0043] As an implementation manner, the first interface includes:

[0044] A first display area, wherein the first display area is used to display the first target image;

[0045] a second display area, the second display area being used to display the second target image, or being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0046] Preferably, the first display area and the second display area are arranged and distributed along a first direction; or, the first display area and the second display area are arranged and distributed along a second direction; wherein the first direction and the second direction are perpendicular to each other.

[0047] As an implementation manner, the display device is further used to display a second interface, and the second interface is used to display management information of the blood sample;

[0048] The trigger instruction includes: an instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input.

[0049] As an implementation manner, controlling the display device to display the first interface includes: controlling the display device to display the first interface in a pop-up window in a local area of ​​the second interface;

[0050] Alternatively, controlling the display device to display the first interface includes: controlling the display device to switch from displaying the second interface to displaying the first interface in a switching manner.

[0051] As an implementation manner, the control device is further configured to: control the display device to mark at least one of the following information on the first interface:

[0052] Information used to indicate that the hematocrit test result of the blood sample in the sample container is abnormal;

[0053] Information used to indicate that a clot detection result of the blood sample in the sample container is abnormal;

[0054] Information used to indicate that a result of a test on the amount of the blood sample in the sample container is abnormal;

[0055] Information used to characterize that the hemolysis test result of the blood sample in the sample container is abnormal;

[0056] Information used to indicate that the jaundice test result of the blood sample in the sample container is abnormal;

[0057] Information used to characterize that the lipemia test result of the blood sample in the sample container is abnormal.

[0058] As an embodiment, the control device is further configured to: obtain information for characterizing a clot detection result of the blood sample in the sample container according to the first target image or according to the first target image and the second target image;

[0059] And / or, the first target image is used as a basis for at least one of the following: for an operator to determine whether there is a clot in the intermediate layer liquid, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information in the first interface used to characterize the clot detection result of the blood sample in the sample container is accurate.

[0060] As an embodiment, the control device is further configured to: obtain, according to the second target image, at least one of the following test result information: information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container;

[0061] And / or, the second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

[0062] As an implementation manner, the control device is further configured to:

[0063] According to the second target image, obtaining the total liquid level of the blood sample in the sample container and the height of the lower layer of liquid;

[0064] According to the total liquid level, obtaining information for characterizing a liquid volume detection result of the blood sample in the sample container;

[0065] Information for characterizing a hematocrit test result of the blood sample in the sample container is obtained according to the total liquid level and the height of the lower layer of liquid.

[0066] As an embodiment, obtaining information for characterizing a liquid volume detection result of the blood sample in the sample container according to the total liquid level includes: obtaining information for characterizing a liquid volume detection result of the blood sample in the sample container according to the total liquid level and a conversion function pre-stored in the sample analysis device or obtained according to a conversion function calibration process, wherein the conversion function is a conversion relationship between the liquid level in the sample container and the volume of the blood sample;

[0067] The obtaining, according to the total liquid level and the height of the lower layer liquid, information used to characterize the hematocrit test result of the blood sample in the sample container comprises: obtaining, according to the total liquid level, the height of the lower layer liquid and the conversion function, information used to characterize the hematocrit test result of the blood sample in the sample container;

[0068] Alternatively, obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level includes: obtaining a conversion function corresponding to the type of the sample container and pre-stored in the sample analysis device or obtained according to a conversion function calibration process according to the type of the sample container, and obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level and the conversion function, wherein the conversion function is a conversion relationship between the liquid level in the sample container and the volume of the blood sample;

[0069] The obtaining, according to the total liquid level and the height of the lower layer liquid, information used to characterize the hematocrit test result of the blood sample in the sample container comprises: obtaining, according to the total liquid level, the height of the lower layer liquid and the conversion function, information used to characterize the hematocrit test result of the blood sample in the sample container;

[0070] Alternatively, obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level may include: obtaining a size parameter of the sample container according to an instruction input by an operator through a human-computer interaction device; obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level and the size parameter;

[0071] The obtaining, based on the total liquid level and the height of the lower layer liquid, of information used to characterize a hematocrit test result of the blood sample in the sample container comprises: obtaining, based on the total liquid level, the height of the lower layer liquid and the size parameter, information used to characterize a hematocrit test result of the blood sample in the sample container.

[0072] As an embodiment, the imaging device includes a first imaging device and a second imaging device, wherein the first imaging device is used to perform a first photographing action on the sample container from obliquely above or obliquely below the middle layer liquid loaded in the sample container before the sample measuring device absorbs the upper layer liquid from the sample container;

[0073] The second imaging device is used to perform a second photographing action on the sample container before the sample measuring device absorbs the upper layer of liquid from the sample container;

[0074] The control device is further configured to: obtain the first target image according to information fed back by the first imaging device when performing the first shooting action; and obtain the second target image according to information fed back by the second imaging device when performing the second shooting action;

[0075] The second imaging device and the first imaging device are two independent imaging devices, or the second imaging device and the first imaging device are the same imaging device;

[0076] Preferably, the first imaging device performing the first shooting action on the sample container includes: the first imaging device directly shoots the image of the sample container from obliquely above or below the intermediate layer of liquid or indirectly shoots the image through a first reflector.

[0077] As an embodiment, the second imaging device is used to perform the second imaging action on the sample container along a horizontal direction, before the first imaging device performs the first imaging action on the sample container, on the sample container loaded with the blood sample and after the blood sample is centrifuged and layered;

[0078] The control device is further configured to: before acquiring the first target image, first control the second imaging device to perform the second shooting action on the sample container loaded with the blood sample and after the blood sample is centrifuged and layered, obtain the height position of the interface liquid surface or the interface liquid layer according to the image captured by the second imaging device when performing the second shooting action, and obtain the target height position according to the height position of the interface liquid surface or the interface liquid layer;

[0079] The first target image is obtained based on information fed back from the first imaging device executing the first shooting action, including: controlling one of the sample container and the first imaging device to move relative to the other and stop at the target height position, controlling the first imaging device to execute the first shooting action on the sample container, and obtaining the first target image based on an image captured by the first imaging device executing the first shooting action.

[0080] As an embodiment, the sample analysis device further includes a sample management device and a sample container transmission device;

[0081] The sample management device is at least used for placing a sample container loaded with a blood sample to achieve the loading of the blood sample;

[0082] The sample container transfer device is used to transfer the sample container loaded with the blood sample from the sample management device to the sample measurement device;

[0083] The sample container transmission device comprises a conveying track, a first sample container scheduling mechanism and a sample container transfer device, wherein the conveying track is used to convey a sample seat having a single first container position, wherein the first container position is used to place a single sample container;

[0084] The first sample scheduling mechanism is used to schedule the sample container placed in the sample management device and loaded with the blood sample to the sample seat located on the conveying track;

[0085] The sample container transfer device comprises a sample seat scheduling mechanism, a second sample container scheduling mechanism and a sample rack scheduling mechanism, wherein the sample seat scheduling mechanism is at least used to transport the sample seat transported by the transport track to the sample container transfer device to a rack position, and the second sample container scheduling mechanism is used to schedule the sample container on the sample seat at the rack position to a sample rack provided by the sample rack scheduling mechanism, wherein the sample rack has at least two second container positions, each of which is used to place a single sample container; the sample rack scheduling mechanism is used to schedule the sample rack loaded with sample containers and blood samples in the sample containers to the sample measurement device;

[0086] The first imaging device is used to perform the first photographing action on the sample container transferred by the sample container transfer device to the first photographing position, the first photographing position is located in the sample container transfer device, the first photographing position is set on the path of the sample container transferred by the sample container transfer device and is located between the conveying track and the sample measuring device;

[0087] Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the transport track to the first photographing position, the first photographing position is located on the transport track, the first photographing position is arranged on the path of the transport track transporting the sample container and is located between the first sample scheduling mechanism and the sample container transfer device;

[0088] Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the sample measuring device to the first photographing position, and the first photographing position is located in the sample measuring device. The first photographing position is set on the path of the sample measuring device for transporting the sample container and is located before the sample suction position of the sample measuring device.

[0089] As an embodiment, the sample analysis device further includes a sample management device, a sample container transmission device and a centrifugal device;

[0090] The centrifugal device is used to centrifuge the sample container loaded with the blood sample so that the blood sample is centrifugally separated into the upper layer of liquid, the middle layer of liquid, and the lower layer of liquid;

[0091] The sample management device is used for placing a sample container loaded with a blood sample and not subjected to a centrifugal operation to achieve the loading of the uncentrifuged blood sample, and for placing a sample container loaded with a blood sample and subjected to a centrifugal operation to achieve the loading of the centrifuged blood sample;

[0092] The sample container transfer device is at least used to transfer the sample container output from the sample management device and loaded with an uncentrifuged blood sample to the centrifuge device for centrifugation, to transfer the sample container output from the centrifuge device and loaded with a centrifuged blood sample to the sample measurement device, and to transfer the sample container output from the sample management device and loaded with a centrifuged blood sample to the sample measurement device.

[0093] The first imaging device is used to perform the first photographing action on the sample container transported by the sample container transport device to the first photographing position, and the first photographing position is provided on the path where the sample container transport device transports the sample container from the sample management device to the sample measurement device and is located between the centrifuge device and the sample measurement device;

[0094] Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the sample measuring device to the first photographing position, and the first photographing position is located in the sample measuring device. The first photographing position is set on the path of the sample measuring device for transporting the sample container and is located before the sample suction position of the sample measuring device.

[0095] As an embodiment, the sample analysis device is a sample analysis pipeline or a sample analysis cascade system, and the sample analysis device also includes a sample management device and a sample container transmission device, the sample management device is at least used for placing a sample container loaded with a blood sample to achieve blood sample loading, and the sample container transmission device is used to transmit the sample container loaded with a blood sample from the sample management device to the sample measurement device; the display device includes a first display screen, the first display screen is located next to the sample management device or next to the sample container transmission device, and the first display screen is used to display the first interface, the storage information of the blood sample in the sample management device, and the information of the blood sample transmitted by the sample container transmission device; or,

[0096] The sample analysis equipment is a sample analysis pipeline or a sample analysis cascade system or a single sample analyzer. The display device includes a second display screen provided on the sample measurement device. The second display screen is at least used to display the first interface and measurement item information of the blood sample in the sample measurement device.

[0097] A second object of the present invention is to provide a sample analysis device, the sample analysis device comprising:

[0098] A sample measuring device, the sample measuring device is used to draw at least part of the upper layer liquid from a sample container loaded with a blood sample and after the blood sample is centrifuged and separated into an upper layer liquid, a middle layer liquid, and a lower layer liquid, and distribute the upper layer liquid to a reaction container for measurement, wherein the middle layer liquid at least contains platelets and / or leukocytes;

[0099] a camera device, the camera device being used to photograph the sample container loaded with the blood sample and after the blood sample is centrifuged and separated into the upper layer liquid, the middle layer liquid, and the lower layer liquid before the sample measuring device draws the upper layer liquid from the sample container;

[0100] a display device, the display device being used to display a first interface, the first interface being used to display a first target image obtained by photographing the sample container by the camera device, and displaying at least one of a second target image obtained by photographing the sample container by the camera device, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0101] A control device, the control device being configured to: in response to a trigger instruction, control the display device to display the first interface;

[0102] The first target image is used as a basis for at least one of the following: for an operator to determine whether the intermediate layer of liquid has a clot, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information displayed in the first interface for characterizing the clot detection result of the blood sample in the sample container is accurate;

[0103] The second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

[0104] As an embodiment, the first interface is used to display the first target image and the second target image, and display at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0105] Preferably, the first interface is used to display the first target image, the second target image, information characterizing the hematocrit test result of the blood sample in the sample container, information characterizing the clot test result of the blood sample in the sample container, information characterizing the liquid volume test result of the blood sample in the sample container, information characterizing the hemolysis test result of the blood sample in the sample container, information characterizing the jaundice test result of the blood sample in the sample container, and information characterizing the lipemia test result of the blood sample in the sample container.

[0106] As an implementation manner, the first interface includes:

[0107] A first display area, wherein the first display area is used to display the first target image;

[0108] a second display area, wherein the second display area is used to display the second target image;

[0109] a third display area, the third display area being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container;

[0110] Preferably, the first display area, the second display area and the third display area are distributed in the following manner:

[0111] The first display area, the second display area and the third display area are arranged and distributed along a first direction;

[0112] The first display area, the second display area and the third display area are arranged and distributed along a second direction;

[0113] Two of the first display area, the second display area and the third display area are arranged and distributed along a first direction, and an area formed by the two together with another one is arranged and distributed along a second direction;

[0114] Two of the first display area, the second display area and the third display area are arranged and distributed along the second direction, and the area formed by the two together with the other one is arranged and distributed along the first direction;

[0115] The first direction and the second direction are perpendicular to each other.

[0116] A third object of the present invention is to provide a control method for a sample analysis device, the control method comprising the following steps:

[0117] Controlling the display device to display a second interface;

[0118] In response to a trigger instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device to display the first interface;

[0119] The first interface displays a first target image obtained by photographing a sample container loaded with a blood sample and after the blood sample is centrifugally separated into an upper layer of liquid, a middle layer of liquid, and a lower layer of liquid by a camera device, and displays at least one of a second target image obtained by photographing the sample container by the camera device, information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0120] The intermediate layer liquid contains at least platelets and / or leukocytes;

[0121] There is a boundary liquid surface or boundary liquid layer between the intermediate layer liquid and the upper layer liquid;

[0122] The first target image at least includes an image showing the interface liquid surface or the interface liquid layer in a two-dimensional form and / or a three-dimensional form;

[0123] The second target image at least includes an image showing the entire height of at least one side of the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the entire blood sample in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing the liquid surface of the upper liquid layer, the liquid surface of the middle liquid layer, and the liquid surface of the lower liquid layer in the sample container, or at least includes an image showing at least one side of the entire upper liquid layer, the entire middle liquid layer, and the entire lower liquid layer in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the bottom, middle part, and top of the sample container in a two-dimensional and / or three-dimensional form.

[0124] As an implementation manner, controlling the display device to display the first interface includes: controlling the display device to display the first interface in a pop-up window in a local area of ​​the second interface;

[0125] Alternatively, controlling the display device to display the first interface includes: controlling the display device to switch from displaying the second interface to displaying the first interface in a switching manner.

[0126] As an embodiment, the first interface displays the first target image and the second target image, and displays at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0127] Preferably, the first interface displays the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

[0128] A fourth object of the present invention is to provide a control method for a sample analysis device, the control method comprising the following steps:

[0129] Controlling the display device to display a second interface;

[0130] In response to a trigger instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device to display the first interface;

[0131] The first interface displays a first target image obtained by photographing a sample container loaded with a blood sample and after the blood sample is centrifugally separated into an upper layer of liquid, a middle layer of liquid, and a lower layer of liquid by a camera device, and displays at least one of a second target image obtained by photographing the sample container by the camera device, information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0132] The first target image is used as a basis for at least one of the following: for an operator to determine whether the intermediate layer of liquid has a clot, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information displayed in the first interface for characterizing the clot detection result of the blood sample in the sample container is accurate;

[0133] The second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

[0134] As an embodiment, the first interface displays the first target image and the second target image, and displays at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container;

[0135] Preferably, the first interface displays the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

[0136] The sample analysis device and control method thereof provided by the present invention display, on a first interface, a first target image obtained by photographing a sample container by a camera device through a display device, and the first target image at least includes an image of an interface liquid surface or an interface liquid layer formed between an intermediate layer liquid and an upper layer liquid in a two-dimensional form and / or a three-dimensional form, that is, the first target image at least includes an image of a white film layer in a two-dimensional form and / or a three-dimensional form, and the white film layer image can be used as a basis for judging and reviewing the clot detection result of a blood sample, so that an operator can intuitively judge or review whether there is an abnormal clot phenomenon in a blood sample through the first interface, thereby facilitating improving the efficiency and intuitiveness of the clot detection quality review. In addition, in addition to displaying the first target image on the first interface, the present invention also displays on the first interface a second target image obtained by photographing the sample container by the camera device, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container, and the second target image at least includes an image used to characterize the entire height of the sample container or an image used to characterize the entire height of the blood sample in the sample container. In this way, the operator can view at least two quality inspection-related information of the same blood sample through the same interface, thereby reducing the time for the operator to find information related to the blood sample quality inspection, and further improving the efficiency of the blood sample quality review. BRIEF DESCRIPTION OF THE DRAWINGS

[0137] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the structures shown in these drawings without paying creative work.

[0138] Figure 1 is a schematic diagram of a first interface of a sample analysis device provided by an embodiment of the present invention;

[0139] Figure 2 This is a schematic diagram of the distribution of the camera device provided by an embodiment of the present invention in a sample analysis device;

[0140] Figure 3 is another schematic diagram of the distribution of the camera device in the sample analysis device provided by the embodiment of the present invention;

[0141] Figure 4is another schematic diagram of the distribution of the camera device in the sample analysis device provided by the embodiment of the present invention;

[0142] Figure 5 is a schematic diagram of a first imaging device provided by an embodiment of the present invention indirectly capturing an image of a sample container through a first reflecting mirror;

[0143] Figure 6 is a schematic diagram of directly photographing a sample image by a first imaging device provided by an embodiment of the present invention;

[0144] Figure 7 is a schematic diagram of a second imaging device provided by an embodiment of the present invention indirectly capturing an image of a sample container through a second reflecting mirror;

[0145] Figure 8 It is a schematic diagram of the second imaging device provided in an embodiment of the present invention directly capturing an image of a sample container.

[0146] Description of the accompanying drawings: 10, sample analysis equipment; 100, sample management device; 200, sample measurement device; 210, sample suction channel; 300, sample container transmission device; 310, conveying track; 320, first sample container scheduling mechanism; 330, sample container transfer device; 400, first camera device; 500, control device; 600, first reflector; 700, second camera device; 800, first fill light component; 900, centrifugal device; 101, display device; 1 011, first display screen; 1012, first interface; 1012a, first display area; 1012b, second display area; 1012c, third display area; 1012d, first target image; 1012e, second target image; 102, second reflector; 103, second fill light component; 20, sample container; 30, blood sample; 31, upper layer of liquid; 32, middle layer of liquid; 321, interface liquid surface; 33, lower layer of liquid; X, first direction; Y, second direction. DETAILED DESCRIPTION

[0147] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0148] The sample analysis device provided in the embodiment of the present application is suitable for use in an analysis device having a display device and the object to be tested at least includes a blood sample collected from a human body or an animal. The blood sample is tested by the sample analysis device including but not limited to coagulation test items.

[0149] Prior to this application, the errors in the coagulation test results of some blood samples were caused by the quality of the blood samples before the coagulation test. Therefore, it is very important for the coagulation test project to test the sample quality of the blood sample before the coagulation test. The quality test of the blood sample before the coagulation test includes but is not limited to: HIL test (i.e. hemolysis, jaundice, lipemia test), total fluid volume test, HCT (i.e. hematocrit or hematocrit test), and clot test. Among them, the impact of HIL on the coagulation test results is mainly reflected in: if the anti-interference ability of the coagulation test project is exceeded, the coagulation test results may be inaccurate. Regarding the liquid volume and HCT of blood samples, there are clear provisions in the "Ws / T359-2011 Guidelines for the Collection and Processing of Blood Samples for Plasma Coagulation Tests" and CLSI "H21-A5": The liquid volume of blood samples used for coagulation testing must not be less than the preset threshold (for example, the difference between the total liquid volume of the collected blood sample and the labeled volume is greater than 10%); if the hematocrit of the blood sample is greater than or equal to 55%, or the hematocrit of the blood sample is less than or equal to 20%, the proportion of the anticoagulant needs to be adjusted. The influence of abnormal coagulation in blood samples on the coagulation test results includes two aspects: on the one hand, the sample needle encounters the clot when aspirating the blood sample, resulting in inaccurate sample volume; on the other hand, as long as there is a clot in the blood sample, it means that the blood sample has started the coagulation process, resulting in the consumption of coagulation factors. At this time, even if the sample needle does not encounter the clot and the sample volume is accurate, it will also cause abnormal coagulation test results. Although this abnormality reflects the coagulation state of the blood sample, it cannot accurately reflect the coagulation parameters of the patient.

[0150] In a related art prior to the present application, the detection method of HIL is: by measuring the absorbance at different wavelengths by sampling, the jaundice, hemolysis, and lipemia of the blood sample are obtained, and then whether the blood sample has jaundice, hemolysis, and lipemia, or the level and concentration of jaundice, hemolysis, and lipemia are displayed;

[0151] In a related technology prior to the present application, a method for detecting whether a blood sample has abnormal clotting phenomenon is to perform a sample aspiration test to confirm the liquid level of the blood sample to determine whether the total liquid volume of the blood sample is sufficient, and to confirm whether there is abnormal clotting phenomenon based on the pressure of the aspiration.

[0152] In a related technology prior to the present application, one way for a coagulation detection device to obtain HCT test results is to obtain the HCT test results of the same patient measured by a hematology analyzer (also known as a blood cell analyzer) on a LIS system (i.e., a laboratory information management system).

[0153] like Figures 1 to 8As shown, a first aspect of an embodiment of the present invention provides a sample analysis device 10, which includes a sample measurement device 200, a camera device, and a display device 101. The sample measurement device 200 is used to measure a blood sample 30, that is, the sample measurement device 200 is used to perform measurement items on the blood sample 30. The camera device is used to photograph a sample container 20 loaded with the blood sample 30 before the sample measurement device 200 measures the blood sample 30, that is, the camera device is used to photograph the sample container 20 and / or the image of the blood sample 30 in the sample container 20 before the sample measurement device 200 performs the measurement items on the blood sample 30. The display device 101 is used to display a first interface 1012, and the first interface 1012 is at least used to display a sample image obtained by photographing the sample container 20 by the camera device. The sample image includes an image of the sample container 20 and / or an image of the blood sample 30 in the sample container 20. In this embodiment, by displaying the sample image through the first interface 1012, operators (including but not limited to medical personnel and laboratory staff) can view the image of the sample container 20 and / or the blood sample 30 in the sample container 20 through the first interface 1012, so that the operator can intuitively judge or review the quality of the blood sample 30 in combination with the sample image, thereby helping to improve the intuitiveness of the quality review of the blood sample 30.

[0154] As an embodiment, the sample measuring device 200 is used to measure the centrifuged blood sample 30, that is, the sample measuring device 200 is used to draw at least a portion of the centrifuged blood sample 30 from the sample container 20 loaded with the blood sample 30 and after the blood sample 30 has been centrifuged, and distribute it to the reaction container for reaction and measurement. The camera device is used to photograph the centrifuged sample container 20 before the sample measuring device 200 measures the blood sample 30. The above-mentioned sample image is an image obtained by the camera device photographing the centrifuged sample container 20.

[0155] As an embodiment, the sample measuring device 200 is used to absorb at least part of the upper layer liquid 31 from the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper layer liquid 31, the middle layer liquid 32, and the lower layer liquid 33, and distribute it to the reaction container for measurement, that is: the above-mentioned sample measuring device 200 is used to measure the blood sample 30, including: the sample measuring device 200 is used to absorb at least part of the upper layer liquid 31 from the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper layer liquid 31, the middle layer liquid 32, and the lower layer liquid 33, and distribute it to the reaction container for measurement. The middle layer liquid 32 at least contains platelets and / or white blood cells. The middle layer liquid 32 is also called the buffy coat layer, the upper layer liquid 31 is plasma or serum, and the lower layer liquid 33 is red blood cells. The blood sample 30 collected from a human body or an animal and stored in the sample container 20 is a whole blood sample. In this embodiment, the sample measuring device 200 is used to perform measurement items on the upper layer liquid 31 obtained after the blood sample 30 is centrifuged. Of course, in specific applications, as an alternative implementation, other measuring devices may be provided in the sample analysis device 10 for performing measurement items on the middle layer liquid and / or the lower layer liquid 33; or, as another alternative implementation, other measuring devices may be provided in the sample analysis device 10 for performing measurement items on an uncentrifuged blood sample 30 (i.e., a whole blood sample).

[0156] As an embodiment, the camera device is used to photograph the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper liquid 31, the middle liquid 32, and the lower liquid 33 before the sample measuring device 200 draws the upper liquid 31 from the sample container 20; that is, the camera device photographs the sample container 20 loaded with the blood sample 30 before the sample measuring device 200 measures the blood sample 30, including: the camera device photographs the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper liquid 31, the middle liquid 32, and the lower liquid 33 before the sample measuring device 200 draws the upper liquid 31 from the sample container 20. In this embodiment, the camera device is mainly used to photograph the sample container 20 after centrifugation and before sample aspiration, so as to obtain an image of the blood sample 30 before the measurement item is performed, so as to facilitate the quality inspection of the blood sample 30 according to the image and facilitate the operator to review the quality information of the blood sample 30.

[0157] As an embodiment, the sample image includes a first target image 1012d and / or a second target image 1012e. There is a boundary liquid surface 321 or a boundary liquid layer between the middle layer liquid 32 and the upper layer liquid 31; the first target image 1012d at least includes an image showing the boundary liquid surface 321 or the boundary liquid layer in a two-dimensional form and / or a three-dimensional form; the second target image 1012e at least includes an image showing the entire height of at least one side of the sample container 20 in a two-dimensional form and / or a three-dimensional form, or at least includes an image showing at least one side of all the blood samples 30 in the sample container 20 in a two-dimensional form and / or a three-dimensional form, or at least includes an image showing the liquid surface of the upper layer liquid 31, the liquid surface of the middle layer liquid 32 and the liquid surface of the lower layer liquid 33 in the sample container, or at least includes an image showing at least one side of all the upper layer liquid 31, all the middle layer liquid 32 and all the lower layer liquid 33 in the sample container 20 in a two-dimensional form and / or a three-dimensional form, or at least includes an image showing at least one side of the bottom, middle part and top of the sample container 20 in a two-dimensional form and / or a three-dimensional form. The first target image 1012d can show the image of the buffy coat layer. For the convenience of description and understanding, the first target image 1012d can also be called the buffy coat layer image. The second target image 1012e is a full-view image of the sample container 20 (it can be a full-view image of the sample container 20 with a cap, or it can also be a full-view image of the sample container 20 without a cap, or it can be a full-view image of the sample container 20 with a stopper, or it can be a full-view image of the sample container 20 without a stopper), which can at least show the entire height information of the sample container 20; or the second target image 1012e is a full-view image of the blood sample 30 in the sample container 20, which can at least show the height information of the three layers of the liquid surface of the blood sample 30 in the sample container 20 or the entire height information. For the convenience of description and understanding, the second target image 1012e can also be called the full-view image of the blood sample 30. A one-dimensional shape refers to a shape that extends in only one direction. A one-dimensional shape has only length elements, such as lines, points, etc. Two-dimensional shape refers to a shape that only extends in two directions, and the two-dimensional shape has only two elements of length and width, such as a plane. Three-dimensional shape refers to a shape that has three directions, and the three-dimensional shape has three elements of length, width, and height. In the related art before this application, there is also a scheme of using a camera device to shoot the sample container 20 from the side of the sample container 20. In the scheme of the related art, although the image captured also includes an image of the interface liquid surface 321, the interface liquid surface 321 is displayed in the form of a line, which is used to determine the height position of the interface liquid surface 321; due to the scheme of the related art, the two-dimensional shape and / or three-dimensional shape of the interface liquid surface 321 or the interface liquid layer cannot be seen, so it cannot be used as a basis for clot detection of the intermediate layer liquid 32.In the present application, the interface liquid surface 321 or the interface liquid layer is displayed in two-dimensional and / or three-dimensional form through an image, which is helpful to see whether the interface liquid surface 321 or the interface liquid layer has unevenness problems, so that the image containing the interface liquid surface 321 or the interface liquid layer displayed in two-dimensional and / or three-dimensional form can be used as a basis for clot detection of the intermediate layer liquid 32.

[0158] As an embodiment, the first interface 1012 is used to display at least one of the first target image 1012d obtained by photographing the sample container 20 by the camera device, the second target image 1012e obtained by photographing the sample container 20 by the camera device, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. Hematocrit is also called hematocrit, and its full English name is hematocrit, abbreviated as HCT, which specifically refers to the relative proportion of the volume occupied by red blood cells in the blood sample 30. The hematocrit test result is the result obtained by performing a hematocrit test on the blood sample 30. The clot detection result is the result of clot detection on the blood sample 30. The liquid volume detection result is the result of total liquid volume detection on the blood sample 30. The hemolysis detection result is the result of hemolysis index (Hemolysis Index) detection on the blood sample 30. The icterus detection result is the result of icterus index (Icterus Index) detection on the blood sample 30. The lipemia detection result is the result of lipemia index (Lipemia Index) detection on the blood sample 30. The hemolysis index, icterus index and lipemia index can be collectively referred to as HIL. The setting of the first interface 1012 allows the operator (including but not limited to medical personnel and laboratory staff) to view the white film layer image of the blood sample 30 in the sample container 20, as well as the full image of the blood sample 30, and at least one of the hematocrit test result, clot test result, fluid volume test result, hemolysis test result, jaundice test result and lipemia test result of the blood sample 30 through the same interface, so that the operator can view at least two quality test related information of the same blood sample 30 through the same interface. In this way, on the one hand, it can help reduce the time for the operator to find the relevant information of the quality test of the blood sample 30, and then it can help improve the intuitive and rapid judgment or review of the quality of the blood sample 30, and finally it can help improve the efficiency of the quality review of the blood sample 30. In addition, the display of the white film layer image is convenient for the operator to quickly and intuitively judge or review the clot test result of the blood sample 30.

[0159] As an implementation, the sample analysis device 10 further includes a control device 500 , which is configured to: in response to a trigger instruction, control the display device 101 to display the first interface 1012 . The display device 101 is used to display the first interface 1012 under the control of the control device 500 .

[0160] As an implementation mode, the trigger instruction is an instruction generated by human-computer interaction, so that the operator can control the display device 101 to display the first interface 1012 through human-computer interaction, thereby viewing the information displayed on the first interface 1012. Of course, in specific applications, the setting method of the trigger instruction is not limited to this. As an alternative implementation mode, the trigger instruction can also be an instruction automatically triggered according to the conditions pre-stored in the sample analysis device 10. For example, after the camera device completes shooting the sample container 20, the control device 500 automatically controls the display device 101 to display the first interface 1012.

[0161] As an embodiment, the display device 101 is also used to display a second interface, and the second interface is used to display the management information of the blood sample 30; the trigger instruction includes: an instruction formed by the operator viewing a blood sample 30 in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input. That is, the above-mentioned instruction generated by human-computer interaction includes: an instruction formed by the operator viewing a blood sample 30 in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input. The second interface displays at least one of the following management information of at least one blood sample 30: status, category, ID, barcode number, location, and patient name. The operator can generate a trigger instruction by clicking on any blood sample 30 on the second interface to control the display device 101 to display the first interface 1012. The second interface is the management interface of the blood sample 30. In this embodiment, the operator can view the first interface 1012 by performing human-computer interaction on the management interface of the blood sample 30, which is convenient to operate. Of course, in a specific application, the method of viewing the first interface 1012 is not limited thereto. In an alternative implementation scheme, the first interface 1012 can also be viewed through other interfaces.

[0162] As an embodiment, the above-mentioned control display device 101 displays the first interface 1012, including: controlling the display device 101 to display the first interface 1012 in a local area of ​​the second interface in a pop-up window form. The first interface 1012 is displayed in a pop-up window form, specifically, a window or dialog box is placed on top of the second interface, and the window contains the first interface 1012 and a close button. The first interface 1012 is displayed in a pop-up window form, and the derivative viewing operation can be completed without leaving the second interface. When viewing the first interface 1012, part of the content on the second interface can be viewed synchronously, which is convenient for the operator to confirm the information of the blood sample 30 in combination with the first interface 1012 and the second interface; and after viewing the first interface 1012, the first interface 1012 is closed, and the operator can continue to operate on the second interface without having to search for the second interface again. Of course, in a specific application, as an alternative implementation, viewing the first interface 1012 on the basis of the second interface is not limited to displaying the first interface 1012 in a pop-up window. For example, as an alternative implementation, the above-mentioned control of the display device 101 to display the first interface 1012 includes: controlling the display device 101 to switch from displaying the second interface to displaying the first interface 1012 in a switching form. This alternative implementation means that the user can jump from the second interface to the first interface 1012 in the form of interface switching.

[0163] As an embodiment, the first interface 1012 displays a first target image 1012d obtained by photographing the sample container 20 by the camera device, and displays a second target image 1012e obtained by photographing the sample container 20 by the camera device, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipid blood test result of the blood sample 30 in the sample container 20. At least one of the information of the test results includes: the first interface 1012 displays at least two information related to the quality detection of the blood sample 30; or, the first interface 1012 displays at least three information related to the quality detection of the blood sample 30; or, the first interface 1012 displays at least four information related to the quality detection of the blood sample 30; or, the first interface 1012 displays at least five information related to the quality detection of the blood sample 30; or, the first interface 1012 displays at least seven information related to the quality detection of the blood sample 30; or, the first interface 1012 displays at least eight information related to the quality detection of the blood sample 30; or, the first interface 1012 displays all information related to the quality detection of the blood sample 30.

[0164] As an implementation manner, when the first interface 1012 displays at least two pieces of information (i.e., information related to the quality detection of the blood sample 30), the first interface 1012 is used to display at least a first target image 1012d and a second target image 1012e. In this implementation manner, the at least two pieces of information displayed on the first interface 1012 are a buffy coat image and a full-view image of the same blood sample 30, so that the operator does not need to search for the buffy coat image and the full-view image of the same blood sample 30 through different channels, and the operator can quickly and intuitively review the quality of the blood sample 30 by combining the two images.

[0165] Of course, in a specific application, the at least two pieces of information displayed on the first interface 1012 are not limited to the above-mentioned buffy coat image and full-view image of the same blood sample 30. For example, as an alternative embodiment, the at least two pieces of information displayed on the first interface 1012 include the buffy coat image and the clot detection result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display at least the first target image 1012d and the information used to characterize the clot detection result of the blood sample 30 in the sample container 20.

[0166] Alternatively, as another alternative embodiment, the at least two pieces of information displayed on the first interface 1012 include a buffy coat image and a hematocrit test result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is at least used to display a first target image 1012d and information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20.

[0167] As an embodiment, the first interface 1012 displays at least three pieces of information, namely: the first interface 1012 is used to display the first target image 1012d, and at least two of the second target image 1012e, information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least three pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0168] As an embodiment, when the first interface 1012 displays at least three pieces of information, the first interface 1012 is used to display the first target image 1012d and the second target image 1012e, and display at least one of the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, the information used to characterize the clot test result of the blood sample 30 in the sample container 20, the information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, the information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the at least three pieces of information displayed on the first interface 1012 include the buffy coat image, the full view image, and at least one quality test result of the same blood sample 30, so that the operator can quickly and intuitively review the quality of the blood sample 30 by combining the two images and the at least one quality test result.

[0169] Of course, in a specific application, the at least three pieces of information displayed on the first interface 1012 are not limited to the above-mentioned buffy coat image, full-view image, and at least one quality test result of the same blood sample 30. For example, as an alternative embodiment, the at least three pieces of information displayed on the first interface 1012 include the buffy coat image, clot test result, and at least another quality test result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display the first target image 1012d and information for characterizing the clot test result of the blood sample 30 in the sample container 20, and to display at least one of the information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, the information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, the information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, the information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and the information for characterizing the lipemia test result of the blood sample 30 in the sample container 20.

[0170] Alternatively, as another alternative embodiment, the at least three pieces of information displayed on the first interface 1012 include a buffy coat image, a hematocrit test result, and at least another quality test result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display the first target image 1012d and information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, and to display at least one of information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20.

[0171] As an embodiment, the first interface 1012 displays at least four pieces of information, namely: the first interface 1012 is used to display the first target image 1012d, and at least three of the second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least four pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0172] As an implementation manner, when the first interface 1012 displays at least four pieces of information, the first interface 1012 is used to display at least the first target image 1012d, the second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, and information used to characterize the clot test result of the blood sample 30 in the sample container 20. In this implementation manner, the at least four pieces of information displayed on the first interface 1012 include the buffy coat image, the full image, the hematocrit test result, and the clot test result of the same blood sample 30, so that the operator can quickly and intuitively review the hematocrit test result and the clot test result of the blood sample 30.

[0173] Of course, in a specific application, the at least four information displayed on the first interface 1012 are not limited to the above-mentioned buffy coat image, buffy coat image, full-view image, hematocrit detection result, and clot detection result of the same blood sample 30. For example, as an alternative embodiment, the at least four information displayed on the first interface 1012 include the buffy coat image, full-view image, clot detection result, and liquid volume detection result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display at least the first target image 1012d, the second target image 1012e, the information used to characterize the clot detection result of the blood sample 30 in the sample container 20, and the information used to characterize the liquid volume detection result of the blood sample 30 in the sample container 20.

[0174] Alternatively, as another alternative embodiment, the at least four information displayed on the first interface 1012 include a buffy coat image, a full image, a hematocrit test result, and a liquid volume test result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display at least a first target image 1012d, a second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, and information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20.

[0175] Alternatively, as yet another alternative embodiment, the at least four pieces of information displayed on the first interface 1012 include a buffy coat image, a clot detection result, a hematocrit detection result, and a liquid volume detection result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display at least a first target image 1012d, information for characterizing the clot detection result of the blood sample 30 in the sample container 20, information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20, and information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20.

[0176] Alternatively, as another alternative embodiment, the at least four pieces of information displayed on the first interface 1012 include the white film layer image, hemolysis test results, jaundice test results and lipemia test results of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is at least used to display the first target image 1012d, information used to characterize the hemolysis test results of the blood sample 30 in the sample container 20, information used to characterize the jaundice test results of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test results of the blood sample 30 in the sample container 20.

[0177] As an embodiment, the first interface 1012 displays at least five pieces of information, namely, the first interface 1012 is used to display the first target image 1012d, and at least four of the second target image 1012e, information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least five pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find the information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0178] As an implementation manner, when the first interface 1012 displays at least five pieces of information, the first interface 1012 is used to display at least the first target image 1012d, the second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, and information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20. In this implementation manner, the at least five pieces of information displayed on the first interface 1012 include the buffy coat image, the full image, the hematocrit test result, the clot test result, and the liquid volume test result of the same blood sample 30, so that the operator can quickly and intuitively review the hematocrit test result, the clot test result, and the liquid volume test result of the blood sample 30.

[0179] Of course, in a specific application, the at least five pieces of information displayed on the first interface 1012 are not limited to the above-mentioned buffy coat image, buffy coat image, full-view image, hematocrit test result, clot test result, and fluid volume test result of the same blood sample 30. For example, as an alternative embodiment, the at least five pieces of information displayed on the first interface 1012 include the buffy coat image, full-view image, hemolysis test result, jaundice test result, and lipemia test result of the same blood sample 30, that is, in this alternative embodiment, the first interface 1012 is used to display at least the first target image 1012d, the second target image 1012e, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, the information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0180] As an embodiment, the first interface 1012 displays at least six pieces of information, namely, the first interface 1012 is used to display the first target image 1012d, and at least five of the second target image 1012e, information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least six pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0181] As an embodiment, the first interface 1012 displays at least seven pieces of information, namely, the first interface 1012 is used to display the first target image 1012d, and at least six of the second target image 1012e, information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least seven pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find the information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0182] As an embodiment, when the first interface 1012 displays seven pieces of information, the first interface 1012 is used to display the first target image 1012d, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0183] As an embodiment, the first interface 1012 displays at least eight pieces of information, namely, the first interface 1012 is used to display the first target image 1012d, and at least seven of the second target image 1012e, information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, the operator can view at least eight pieces of quality test-related information of the same blood sample 30 through the same interface, thereby further reducing the time for the operator to find the information related to the quality test of the blood sample 30, and further improving the efficiency of the quality review of the blood sample 30.

[0184] As an embodiment, the first interface 1012 displays all quality inspection-related information of the same blood sample 30, namely: the first interface 1012 is used to display a first target image 1012d, a second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0185] In this embodiment, the operator can view all quality inspection-related information of the same blood sample 30 through the same interface, thereby minimizing the time the operator takes to search for information related to the quality inspection of the blood sample 30, thereby greatly improving the efficiency of the quality review of the blood sample 30.

[0186] Reference Figure 1 and Figure 5As shown, as an embodiment, the first interface 1012 includes a first display area 1012a, a second display area 1012b and a third display area 1012c, the first display area 1012a is used to display a first target image 1012d; the second display area 1012b is used to display a second target image 1012e; the third display area 1012c is used to display at least one of information for characterizing a hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing a clot test result of the blood sample 30 in the sample container 20, information for characterizing a liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing a hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing a jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing a lipemia test result of the blood sample 30 in the sample container 20. The first display area 1012a, the second display area 1012b and the third display area 1012c are independently set, that is, any two of the first display area 1012a, the second display area 1012b and the third display area 1012c do not overlap each other. In this embodiment, three display areas are set on the first interface 1012 to respectively display the white film layer image, the full image and the quality detection result of the same blood sample 30, so that it is convenient for the operator to clearly compare and view the white film layer image, the full image and the quality detection result of the blood sample 30. Of course, in a specific application, as an alternative embodiment, at least two of the first display area 1012a, the second display area 1012b and the third display area 1012c can also be set as at least partially overlapping areas; or, the third display area 1012c can also be further divided into two or more independent display areas.

[0187] As an embodiment, the first display area 1012a, the second display area 1012b, and the third display area 1012c are distributed in the following distribution manner: the first display area 1012a, the second display area 1012b, and the third display area 1012c are arranged and distributed along the first direction X; the first display area 1012a, the second display area 1012b, and the third display area 1012c are arranged and distributed along the second direction Y; two of the first display area 1012a, the second display area 1012b, and the third display area 1012c are arranged and distributed along the first direction X, and the area formed by the two together with the other are arranged and distributed along the second direction Y; two of the first display area 1012a, the second display area 1012b, and the third display area 1012c are arranged and distributed along the second direction Y, and the area formed by the two together with the other are arranged and distributed along the first direction X. The first display area 1012a, the second display area 1012b, and the third display area 1012c may also be arranged along the same direction, or may also be arranged along two directions.

[0188] As an implementation manner, the first direction X and the second direction Y are perpendicular to each other.

[0189] As an implementation manner, the first direction X and the second direction Y are respectively parallel to two adjacent edges of the first interface 1012 .

[0190] As an implementation manner, the first interface 1012 is rectangular, the first direction X is parallel to the long edge of the first interface 1012 , and the second direction Y is parallel to the short edge of the first interface 1012 .

[0191] Reference Figure 1 and Figure 5 As shown, as an embodiment, the third display area 1012c is used to display information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, six pieces of quality test-related information are displayed in the third display area 1012c, realizing six-in-one display on the same interface, which helps to reduce the time for operators to search for information related to the quality test of the blood sample 30. Of course, in specific applications, as an alternative implementation, the third display area 1012c may not display all of the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, the information used to characterize the clot test result of the blood sample 30 in the sample container 20, the information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, the information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20, but may display one, two, three, four, or five of them.

[0192] As an embodiment, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20 are distributed along the second direction Y.

[0193] Reference Figure 1 and Figure 5 As shown, as an embodiment, the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged and distributed along the first direction X, and the second display area 1012b is located between the first display area 1012a and the third display area 1012c. In this embodiment, the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged along the same direction, so that the first display area 1012a, the second display area 1012b and the third display area 1012c can obtain a larger display area in the second direction Y, so as to facilitate the complete and clear display of the full image of the blood sample 30 and the quality detection related information in the limited space of the first interface 1012. In addition, the second display area 1012b is arranged between the first display area 1012a and the third display area 1012c, so that the full image of the blood sample 30 and the quality detection related information that occupy a larger space in the second direction Y are arranged side by side, and the white film layer image of the blood sample 30 that occupies a smaller space in the second direction Y is arranged side by side, which is conducive to improving the coordination and aesthetics of the display content of the first interface 1012. Of course, in specific applications, as an alternative implementation, the third display area 1012c can also be arranged to be located between the first display area 1012a and the third display area 1012c.

[0194] In the above solution, the first interface 1012 is provided with three display areas. Of course, in a specific application, the display areas provided in the first interface 1012 are not limited thereto. For example, as an alternative embodiment, the first interface 1012 may also be provided with only two display areas. In the alternative embodiment, the first interface 1012 includes a first display area 1012a and a second display area 1012b. The first display area 1012a is used to display a first target image 1012d; the second display area 1012b is used to display a second target image 1012e, or to display at least one of information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the clot test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20.

[0195] As an implementation manner, when the first interface 1012 is provided with only two display areas, the first display area 1012a and the second display area 1012b are arranged and distributed along the first direction X; or, the first display area 1012a and the second display area 1012b are arranged and distributed along the second direction Y; wherein the first direction X and the second direction Y are perpendicular to each other. That is, the first display area 1012a and the second display area 1012b can be arranged side by side along the long edge direction of the first interface 1012, or can be arranged side by side along the short edge direction of the first interface 1012.

[0196] As an embodiment, the information used to characterize the liquid volume detection result of the blood sample 30 in the sample container 20 includes at least one of the volume value (the unit of the volume value of the blood sample 30 can be milliliters or liters) and the classification information of normal and abnormal liquid volume. That is, the information used to characterize the liquid volume detection result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in the form of volume value; or it can also be displayed on the first interface 1012 in the form of normal and abnormal classification. Of course, in specific applications, the information used to characterize the liquid volume detection result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0197] As an embodiment, the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 includes at least one of the hematocrit value (in %) and the classification information of normal and abnormal hematocrit. That is, the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in the form of hematocrit value; or can be displayed on the first interface 1012 in the form of normal and abnormal classification. Of course, in specific applications, the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0198] As an embodiment, the information used to characterize the clot detection result of the blood sample 30 in the sample container 20 includes at least one of the clot grade, the probability of clot abnormality, and the classification information of normal and abnormal clots. That is, the information used to characterize the clot detection result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in a graded manner, or can be displayed on the first interface 1012 in a manner of the probability of suspected clot abnormality, or can be displayed on the first interface 1012 in a manner of normal and abnormal clot classification. Of course, in specific applications, the information used to characterize the clot detection result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0199] As an implementation manner, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 includes at least one of the hemolysis index grade, hemolysis concentration, and classification information of normal and abnormal hemolysis index. That is, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in the form of grade; or, it can also be displayed on the first interface 1012 in the form of concentration; or, it can also be displayed on the first interface 1012 in the form of normal and abnormal classification. Of course, in specific applications, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0200] As an implementation manner, the information used to characterize the jaundice detection result of the blood sample 30 in the sample container 20 includes at least one of the jaundice index level, jaundice concentration, and classification information of normal and abnormal jaundice index. That is, the information used to characterize the jaundice detection result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in the form of level; or, it can also be displayed on the first interface 1012 in the form of concentration; or, it can also be displayed on the first interface 1012 in the form of normal and abnormal classification. Of course, in specific applications, the information used to characterize the jaundice detection result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0201] As an embodiment, the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20 includes at least one of the following information: the lipemia index level, the lipemia concentration, and the classification information of the normal and abnormal lipemia index. That is, the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20 can be displayed on the first interface 1012 in the form of level; or, it can be displayed on the first interface 1012 in the form of concentration; or, it can be displayed on the first interface 1012 in the form of normal and abnormal classification. Of course, in specific applications, the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20 can also be displayed on the first interface 1012 in other ways.

[0202] As an embodiment, the control device 500 is further configured to: control the display device 101 to mark at least one of the following information on the first interface 1012: information for indicating that the hematocrit test result of the blood sample 30 in the sample container 20 is abnormal; information for indicating that the clot test result of the blood sample 30 in the sample container 20 is abnormal; information for indicating that the liquid volume test result of the blood sample 30 in the sample container 20 is abnormal; information for indicating that the hemolysis test result of the blood sample 30 in the sample container 20 is abnormal; information for indicating that the jaundice test result of the blood sample 30 in the sample container 20 is abnormal; information for indicating that the lipemia test result of the blood sample 30 in the sample container 20 is abnormal. In this embodiment, in the first interface 1012, the test items with abnormal quality test results are marked in a marking manner, so that the information of the abnormal quality test results is more conspicuous, which is conducive to attracting the attention of the operator to the abnormal test items.

[0203] As an implementation mode, the above-mentioned manner of marking abnormal test results such as hematocrit test results, clot test results, fluid volume test results, hemolysis test results, jaundice test results and lipemia test results on the first interface 1012 includes marking and displaying the abnormal test results in different colors, different fonts, different font sizes, bolding, adding characters, etc. For example: abnormal test results are displayed in red (or yellow, etc.), or abnormal test results are marked with an "!", or abnormal test results are marked with an "*", or abnormal test results are displayed in bold, etc.

[0204] As an embodiment, the abnormal liquid volume detection result includes that the total liquid volume of the blood sample 30 is less than a first threshold value.

[0205] As an embodiment, the abnormal hematocrit test result includes that the hematocrit of the blood sample 30 is greater than the second threshold value or the hematocrit of the blood sample 30 is less than the third threshold value.

[0206] As an embodiment, the abnormal hemolysis test result includes that the hemolysis index of the blood sample 30 is greater than a fourth threshold value.

[0207] As an implementation manner, the abnormal jaundice detection result includes that the jaundice index of the blood sample 30 is greater than a fifth threshold value.

[0208] As an embodiment, an abnormal blood lipid test result includes that the blood lipid index of the blood sample 30 is greater than a sixth threshold value.

[0209] As an embodiment, the control device 500 is further configured to obtain information for characterizing the clot detection result of the blood sample 30 in the sample container 20 according to the first target image 1012d. In this embodiment, the clot is detected by shooting the white film layer image to obtain the detection result of whether the blood sample 30 has a clot abnormality and / or determine the degree of coagulation of the blood sample 30. In the related art before this application, the clot is mainly detected by the pressure detection method, specifically, the pressure curve when the sample needle is aspirated is used to determine whether there is a clot abnormality in the blood sample 30, that is, a pressure sensor is installed in the sample aspiration liquid path of the sample needle. When the sample needle aspirates, if the sample needle touches a clot, it will cause a slight needle blockage, which can be detected from the pressure detection data of the pressure sensor. The pressure detection method has shortcomings in specific applications: after the blood sample 30 is measured, there is no output that can be used as a basis for accurately judging whether the blood sample 30 has a clot before aspirating. Since the blood sample 30 is clotted prematurely, the clot is usually only a small piece. Therefore, when the sample needle is inserted into the blood sample 30 to aspirate the sample, it sometimes contacts a small clot, and sometimes does not contact a clot. In addition, due to the accuracy limitation of the pressure sensor, even if the sample needle touches a small clot, it may not be able to accurately detect the presence of a clot in the blood sample 30. Therefore, the probability of missing the abnormal clot is very high. The implementation scheme provided in this embodiment detects clots by a non-contact imaging method to determine whether the blood sample 30 has an abnormal clot phenomenon before aspirating the sample. Compared with the solution of detecting clots by the pressure change method of aspirating the sample and blocking the needle in the related art, it has the following beneficial effects: the imaging method of the solution in this embodiment is not affected by the size of the clot and the sensitivity of the pressure sensor, which is conducive to reducing the probability of missing the abnormal clot phenomenon in the blood sample 30, and improving the accuracy of determining whether the blood sample 30 has an abnormal clot phenomenon before aspirating the sample.

[0210] In the above scheme, the clot detection result is obtained by the buffy coat image of the blood sample 30. Of course, in a specific application, as an alternative embodiment, the clot detection method is not limited to this. For example, as an alternative embodiment, the clot detection result is obtained by combining the buffy coat image of the blood sample 30 and the sample full-view image, that is, in this alternative embodiment, the control device 500 is further configured to: obtain information for characterizing the clot detection result of the blood sample 30 in the sample container 20 according to the first target image 1012d or according to the first target image 1012d and the second target image 1012e.

[0211] Alternatively, as another alternative embodiment, the clot detection result is obtained by combining the buffy coat image of the blood sample 30, the sample full-view image and the sample needle pressure detection method. In this alternative embodiment, the sample measurement device 200 includes a sample distribution mechanism, the sample distribution mechanism includes a sample needle and a needle blocking detection component, the sample needle is used to absorb at least a portion of the upper layer liquid 31 from the sample container 20 and distribute it to the reaction container, the needle blocking detection component is used to detect the parameters used to characterize whether the needle is blocked during the process of the sample needle absorbing at least a portion of the upper layer liquid 31, and the control device 500 is further configured to: obtain information used to characterize the clot detection result of the blood sample 30 in the sample container 20 according to the first target image 1012d, the second target image 1012e and the feedback information of the needle blocking detection component.

[0212] As an embodiment, the first target image 1012d is used as a basis for at least one of the following: for the operator to determine whether the intermediate layer liquid 32 has a clot, for the operator to determine the degree of coagulation of the blood sample 30, and for the operator to review whether the information in the first interface 1012 used to characterize the clot detection result of the blood sample 30 in the sample container 20 is accurate. The degree of coagulation of the blood sample 30 may include the following three degrees: no premature coagulation, slight premature coagulation, and severe premature coagulation. The degree of coagulation of the blood sample 30 can be determined by whether there is a clot, and the size and number of the clot. The premature coagulation phenomenon of the blood sample 30 specifically refers to: the phenomenon that the blood sample 30 produces a clot before the sample is aspirated. In this embodiment, the white film layer image can be used to determine whether the blood sample 30 has a clot, the degree of the clot, and to review the clot detection result.

[0213] As an embodiment, an abnormal clot detection result includes: a target index for characterizing the flatness of the intermediate layer liquid 32 in the first target image 1012d is greater than or equal to a preset index; or, a similarity between a target feature in the first target image 1012d and a preset feature is greater than or equal to a first preset threshold; or, a similarity between the first target image 1012d and the preset image is greater than or equal to a second preset threshold.

[0214] As an implementation manner, the first target image 1012d at least includes an image showing the interface liquid surface 321 in a two-dimensional form, that is, the first target image 1012d at least includes an image showing the top horizontal liquid surface of the intermediate layer liquid 32 in a two-dimensional form. In this implementation manner, the image of the interface liquid surface 321 is shown in a plane, so that it is helpful to clearly see whether the interface liquid surface 321 has an uneven problem through the first target image 1012d.

[0215] As an embodiment, the first target image 1012d at least includes an image showing the entire interface liquid surface 321 in a two-dimensional form, that is, the first target image 1012d at least includes an image showing the entire top horizontal liquid surface of the intermediate layer liquid 32 in a two-dimensional form. In this embodiment, the image of the entire interface liquid surface 321 is displayed in a plane, so that it is helpful to fully and clearly see whether the interface liquid surface 321 has an uneven problem through the first target image 1012d, which is helpful to avoid the problem of missed detection of clots.

[0216] As an embodiment, the control device 500 is further configured to: control the display device 101 to display on the first interface 1012 information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20; information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20; information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20; information used to characterize the jaundice test result of the blood sample 30 in the sample container 20; information used to characterize the lipemia test result of the blood sample 30 in the sample container 20; and compare the hematocrit test result, clot test result, liquid volume test result, hemolysis test result, jaundice test result and lipemia test result with preset thresholds or preset conditions respectively to determine whether the test result is normal or abnormal, and display the normal and abnormal test results on the first display interface in different ways. In this embodiment, by displaying all quality inspection-related information on the same screen, and by setting abnormal parameter thresholds or conditions for the liquid volume, hematocrit, clot, lipemia index, hemolysis index, and icterus index of the blood sample 30, the display modes of abnormal and normal inspection results are set to be different.

[0217] As an embodiment, the control device 500 is further configured to obtain, according to the second target image 1012e, at least one of the following test result information: information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing the liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing the hemolysis test result of the blood sample 30 in the sample container 20, information for characterizing the jaundice test result of the blood sample 30 in the sample container 20, and information for characterizing the lipemia test result of the blood sample 30 in the sample container 20. In this embodiment, at least one of the hematocrit test result, the liquid volume test result, the hemolysis test result, the jaundice test result, and the lipemia test result is obtained through the full image of the blood sample 30, and the detection method is simple.

[0218] As an implementation manner, the second target image 1012e is used as a basis for at least one of the following: for the operator to review whether the information in the first interface 1012 used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the liquid volume test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the jaundice test result of the blood sample 30 in the sample container 20 is accurate, and for the operator to review whether the information in the first interface 1012 used to characterize the lipemia test result of the blood sample 30 in the sample container 20 is accurate. In this implementation manner, at least one of the hematocrit test result, the liquid volume test result, the hemolysis test result, the jaundice test result, and the lipemia test result is reviewed through the full image of the blood sample 30, which is conducive to improving the intuitiveness and efficiency of the review.

[0219] As an embodiment, the control device 500 is further configured to obtain the following test result information based on the second target image 1012e: information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. And the second target image 1012e is used as the following basis: for the operator to review whether the information in the first interface 1012 used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the liquid volume test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 is accurate, for the operator to review whether the information in the first interface 1012 used to characterize the jaundice test result of the blood sample 30 in the sample container 20 is accurate, and for the operator to review whether the information in the first interface 1012 used to characterize the lipemia test result of the blood sample 30 in the sample container 20 is accurate. This embodiment obtains the hematocrit test results, fluid volume test results, hemolysis test results, jaundice test results and lipemia test results through the full image of the blood sample 30, and uses the full image of the blood sample 30 as a basis for the operator to review the hematocrit test results, fluid volume test results, hemolysis test results, jaundice test results and lipemia test results, which is beneficial to simplify the quality inspection of the blood sample 30 before the coagulation test, and facilitates the intuitiveness and efficiency of the operator's review of the quality of the blood sample 30.

[0220] As an embodiment, the control device 500 is further configured to: obtain the total liquid level of the blood sample 30 in the sample container 20 and the height of the lower layer of liquid 33 according to the second target image 1012e; and obtain information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level. In this embodiment, the liquid volume detection method of the blood sample 30 is: first obtain the total liquid level of the blood sample 30 through the full image of the blood sample 30, and then obtain the liquid volume detection result of the blood sample 30 according to the total liquid level of the blood sample 30. The operation method is simple and is conducive to improving the efficiency and intuitiveness of the liquid volume audit of the blood sample 30.

[0221] As an embodiment, the control device 500 is further configured to obtain information for characterizing the hematocrit test result of the blood sample 30 in the sample container 20 according to the total liquid level and the height of the lower layer liquid 33. The hematocrit test method of the blood sample 30 in this embodiment is as follows: firstly, the total liquid level and the height of the lower layer liquid 33 of the blood sample 30 are obtained through a full image of the blood sample 30, and then, according to the total liquid level and the height of the lower layer liquid 33, the hematocrit test result of the blood sample 30 is obtained.

[0222] As an implementation method of obtaining the liquid volume detection result and the hematocrit detection result according to the total liquid level and the height of the lower liquid 33, the above-mentioned information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level includes: obtaining the information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level and a conversion function pre-stored in the sample analysis device 10, wherein the conversion function is a conversion relationship between the liquid level in the sample container 20 and the volume of the blood sample 30. The above-mentioned information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the height of the lower liquid 33 includes: obtaining the information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level, the height of the lower liquid 33 and the conversion function. Specifically, the liquid volume and hematocrit detection method is: first, according to the full image of the blood sample 30, the total liquid level of the blood sample 30 and the height of the lower layer liquid 33 are obtained, then the total volume of the blood sample 30 is obtained according to the total liquid level and the conversion function of the pre-stored sample analysis device 10, then the volume of the lower layer liquid 33 is obtained according to the height of the lower layer liquid 33 and the conversion function, and then the hematocrit of the blood sample 30 is obtained according to the total volume of the blood sample 30 and the volume of the lower layer liquid 33, thereby completing the liquid volume and hematocrit detection of the blood sample 30. The method of obtaining the liquid volume detection result and the hematocrit detection result of this embodiment is suitable for the case where the sample analysis device 10 only uses one type of sample container 20.

[0223] In specific applications, there are many types of sample containers 20. The shape and size parameters of different types of sample containers 20 will be different. The difference in shape and size of the sample container 20 will affect the accuracy of the conversion result from height to volume, thereby affecting the accuracy of the liquid volume detection result and the hematocrit detection result. Among them, the influence of the shape and size of the sample container 20 on the calculation accuracy of the liquid volume in the sample container 20 is mainly reflected in the following points: 1) The inner diameter of the sample container 20 is different, that is, the inner diameters of different sample containers 20 are different, and it is difficult to achieve a unified inner diameter. 2) There is a draft angle when the sample container 20 is manufactured, resulting in inconsistency between the inner diameter of the tube mouth and the tube bottom of the sample container 20; 3) The shape of the bottom of the sample container 20 is a non-standard hemisphere, and it is difficult to model and calculate the volume of the bottom of the sample container 20. It can be seen that due to the irregular shape of the sample container 20, before performing liquid volume detection and hematocrit detection, it is necessary to obtain in advance the conversion relationship between the liquid level height in this type of sample container 20 and the volume of the blood sample 30 to ensure the accuracy of the conversion result from height to volume.

[0224] In the above scheme, in the process of converting the height to obtain the volume, the conversion function used is pre-stored in the sample analysis device 10, that is, the conversion function is pre-stored in the sample analysis device 10 before the first blood sample 30 is measured after the sample analysis device 10 is installed, and the user end (the actual occasion for the measurement of the blood sample 30, such as the testing room of the hospital) does not need to execute any process to obtain the conversion function. Of course, in a specific application, as an alternative implementation, the conversion function can also be obtained according to the conversion function calibration process, that is, in this alternative implementation, the above-mentioned information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level height includes: according to the total liquid level height and the conversion function obtained according to the conversion function calibration process, the information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 is obtained. The information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 is obtained according to the total liquid level and the height of the lower layer liquid 33, including: the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20 is obtained according to the total liquid level, the height of the lower layer liquid 33 and the conversion function obtained according to the conversion function calibration process. In this alternative embodiment, after the sample analysis device 10 is installed, a conversion function is pre-stored in the sample analysis device 10, and during the use of the user end, an updated conversion function is obtained by further executing the conversion function calibration process at the user end.

[0225] As another embodiment of obtaining the liquid volume detection result and the hematocrit detection result according to the total liquid level and the height of the lower liquid 33, the above-mentioned information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level includes: obtaining a conversion function pre-stored in the sample analysis device 10 and corresponding to the type of the sample container 20 according to the type of the sample container 20, and obtaining information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the conversion function, wherein the conversion function is a conversion relationship between the liquid level in the sample container 20 and the volume of the blood sample 30. The information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the height of the lower liquid 33 includes: obtaining information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level, the height of the lower liquid 33 and the conversion function. The method of obtaining the liquid volume detection result and the hematocrit detection result according to this embodiment is applicable to the case where the sample analysis device 10 uses at least two types of sample containers 20. In the related art prior to the present application, it is difficult to measure the inner diameters of all sample containers 20, which makes it difficult to accurately calculate the liquid volume and hematocrit of the blood sample 30 in each different type of sample container 20 according to the liquid level. In this embodiment, the conversion functions corresponding to the different types of sample containers 20 are pre-stored in the sample analysis device 10 in advance. In this way, in a specific application, only the type information of the sample container 20 and the liquid level of the blood sample 30 in the sample container 20 need to be obtained, and the liquid volume and hematocrit of the blood sample 30 can be converted according to the conversion function. Among them, the type of the sample container 20 can be obtained by a barcode reader or visual shooting, or by loading different types of sample containers 20 separately in different loading areas.

[0226] In the above embodiment, in the process of converting the height to obtain the volume, the conversion function used is pre-stored in the sample analysis device 10. Of course, in a specific application, as an alternative embodiment, the conversion function can also be obtained according to the conversion function calibration process, that is, in this alternative embodiment, the above-mentioned information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level height includes: according to the type of the sample container 20, a conversion function obtained according to the conversion function calibration process and corresponding to the type of the sample container 20 is obtained, and according to the total liquid level and the conversion function, the information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 is obtained. The above-mentioned information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the height of the lower layer liquid 33 includes: according to the total liquid level, the height of the lower layer liquid 33, and the conversion function obtained according to the conversion function calibration process and corresponding to the type of the sample container 20, the information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 is obtained. In this alternative embodiment, after the sample analysis device 10 is installed, the conversion function will be pre-stored in the sample analysis device 10 , and during use at the user end, an updated conversion function will be obtained by further executing a conversion function calibration process at the user end.

[0227] As another embodiment of obtaining the liquid volume detection result and the hematocrit detection result according to the total liquid level and the height of the lower liquid 33, the information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level includes: obtaining the size parameter of the sample container 20 according to the instruction input by the operator through the human-computer interaction device; obtaining the information for characterizing the liquid volume detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the size parameter; the information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level and the height of the lower liquid 33 includes: obtaining the information for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 according to the total liquid level, the height of the lower liquid 33 and the size parameter. In this embodiment, the size parameter of the sample container 20 is obtained by manual input, and the control device 500 can obtain the liquid volume detection result and the hematocrit detection result of the blood sample 30 according to the liquid level obtained by shooting and the size parameter of the sample container 20 input manually. It is not necessary to pre-store the conversion function between the liquid level in the sample container 20 and the volume of the blood sample 30 in the sample analysis device 10 and to set a conversion function calibration process.

[0228] As an embodiment, the imaging device includes a first imaging device 400, and the first imaging device 400 is used to perform a first shooting action on the sample container 20 from the oblique upper or oblique lower side of the intermediate layer liquid 32 loaded in the sample container 20 before the sample measuring device 200 draws the upper layer liquid 31 from the sample container 20; the control device 500 is further configured to obtain a first target image 1012d according to the information fed back by the first imaging device 400 when performing the first shooting action. In this embodiment, the first imaging device 400 shoots the liquid surface image of the white film layer from the oblique upper or oblique lower side of the intermediate layer liquid 32 loaded in the sample container 20, which is conducive to ensuring that the two-dimensional morphological liquid surface image and / or three-dimensional morphological liquid surface image of the white film layer, that is, the two-dimensional morphological and / or three-dimensional morphological image of the interface liquid surface 321 or the interface liquid layer is captured.

[0229] Reference Figure 2 and Figure 5 As shown, as an embodiment, the first imaging device 400 performs the first shooting action on the sample container 20, including: the first imaging device 400 indirectly shoots the image of the sample container 20 from the oblique upper or oblique lower side of the intermediate layer liquid 32 through the first reflector 600. Specifically, the imaging device further includes the first reflector 600, and the first reflector 600 is used to: when the first imaging device 400 performs the first shooting action, reflect the image at least including the interface liquid surface 321 or the interface liquid layer displayed in a two-dimensional form and / or a three-dimensional form to the first imaging device 400. The first imaging device 400 performs the first shooting action on the sample container 20, including: the first imaging device 400 shoots the image of the sample container 20 in the first reflector 600 toward the first reflector 600. Since the first imaging device 400 has a requirement for the focal position when performing the first shooting action, in this embodiment, the first reflector 600 is used to reflect the image of the interface liquid surface 321 or the interface liquid layer in a two-dimensional form and / or a three-dimensional form to the first imaging device 400, which is conducive to changing the propagation path of the light, so that the shooting focal position of the first imaging device 400 is transformed into the distance between the first imaging device 400 and the first reflector 600, thereby facilitating the reduction of the distance between the first imaging device 400 and the sample container 20, and further facilitating the reduction of the volume of the sample analysis device 10. Of course, in specific applications, the sample analysis device 10 may also not be provided with the first reflector 600, for example, refer to Figure 6As shown, as an alternative embodiment, the first imaging device 400 performs a first shooting action on the sample container 20, including: the first imaging device 400 directly shoots an image of the sample container 20 from obliquely above or obliquely below the intermediate layer of liquid 32. As a further embodiment of the alternative embodiment, the first imaging device 400 performs a first shooting action on the sample container 20, including: the first imaging device is used to shoot an image of the sample container 20 directly from obliquely above the intermediate layer of liquid 32 toward the sample container 20 in a posture where the imaging optical axis forms a preset angle with the horizontal direction, and the preset angle is greater than or equal to 10° and less than or equal to 70°.

[0230] As an embodiment, the first reflector 600 is tilted relative to the horizontal direction. The optical axis of the first imaging device 400 when performing the first shooting action is perpendicular to the horizontal direction, that is, the optical axis of the first imaging device 400 when performing the first shooting action is arranged in the vertical direction. The first imaging device 400 can be arranged above or below the first reflector 600 in the vertical direction. Since the sample container 20 is arranged in the vertical direction when performing the first shooting action, that is, the height direction of the sample container 20 is parallel to the vertical direction, the optical axis of the first imaging device 400 is parallel to the height direction of the sample container 20, which is conducive to reducing the horizontal distance between the first imaging device 400 and the sample container 20, thereby helping to reduce the horizontal footprint of the sample analysis device 10. Of course, in specific applications, the arrangement of the first reflector 600 and the first imaging device 400 is not limited to this. For example, the position and orientation of the first reflector 600 and the first imaging device 400 can also be adjusted, that is, the imaging optical axis of the first imaging device 400 is not necessarily along the vertical direction, but can also have a certain inclination angle, as long as the first imaging device 400 can capture an image containing the interface liquid surface 321 or the interface liquid layer displayed in two-dimensional form and / or three-dimensional form through the first reflector 600.

[0231] As an embodiment, the first reflector 600 is used to reflect the image of the sample container 20 from the oblique upper side of the intermediate layer liquid 32 when the first imaging device 400 performs the first shooting action; the first imaging device 400 is used to capture the image of the sample container 20 in the first reflector 600 when performing the first shooting action. In this embodiment, the first reflector 600 reflects upward from the side of the sample container 20 an image including the interface liquid surface 321 or the interface liquid layer displayed in a two-dimensional form and / or a three-dimensional form, and the first imaging device 400 captures the image including the interface liquid surface 321 or the interface liquid layer displayed in a two-dimensional form and / or a three-dimensional form in the first reflector 600 from above the first reflector 600. Of course, in specific applications, the relative positions of the first reflector 600 and the first imaging device 400 are not limited thereto. For example, as an alternative embodiment, the first reflector 600 is used to reflect the image of the sample container 20 from obliquely below the intermediate layer of liquid 32 when the first imaging device 400 performs the first shooting action; the first imaging device 400 is used to capture the image of the sample container 20 in the first reflector 600 when performing the first shooting action. In this alternative embodiment, the first reflector 600 reflects downward from the side of the sample container 20 an image including the interface liquid surface 321 or the interface liquid layer displayed in a two-dimensional form and / or a three-dimensional form, and the first imaging device 400 captures the image including the interface liquid surface 321 or the interface liquid layer displayed in a two-dimensional form and / or a three-dimensional form in the first reflector 600 from below the first reflector 600.

[0232] As an embodiment, the sample analysis device 10 further includes a first fill light component 800, which is used to emit light toward the sample container 20 in the first shooting action to illuminate the sample container 20. The first fill light component 800 can be disposed on the front or side of the sample container 20, or on the top or other positions of the sample container 20.

[0233] As an implementation manner, the first imaging device 400 is a first camera, and the first fill light component 800 is an array LED that has been homogenized. Its main purpose is to fill light for the white film layer in the field of view of the first camera to at least illuminate the white film layer.

[0234] Reference Figure 1 , Figure 2 , Figure 7 and Figure 8As shown, as an embodiment, the camera device further includes a second camera device 700, and the second camera device 700 is used to perform a second shooting action on the sample container 20 before the sample measuring device 200 draws the upper layer of liquid 31 from the sample container 20; the control device 500 is further configured to obtain a second target image 1012e according to the information fed back by the second camera device 700 when performing the second shooting action. The second camera device 700 and the first camera device 400 are two independent camera devices, that is, the second camera device 700 and the first camera device 400 are two different camera devices, not the same camera device. In this embodiment, two camera devices are provided, and one of the camera devices is used to capture the full image of the blood sample 30, and the other camera device is used to capture the white film layer image of the blood sample 30, so that the full image of one blood sample 30 and the white film layer image of another blood sample 30 can be captured in parallel, thereby facilitating the improvement of the detection efficiency of batch blood samples 30. Of course, in a specific application, as an alternative implementation, the second imaging device 700 and the first imaging device 400 may also be configured as the same imaging device.

[0235] As an implementation manner, the first imaging device 400 and the second imaging device 700 are respectively located at two different positions. Of course, in a specific application, as an alternative implementation manner, the first imaging device 400 and the second imaging device 700 can also be located at the same position.

[0236] As an implementation, the second imaging device 700 is located in front of the first imaging device 400 along the transmission direction of the sample container 20. The sample container 20 is first transmitted to the shooting position of the second imaging device 700 for shooting, and then transmitted to the shooting position of the first imaging device 400 for shooting.

[0237] As an embodiment, the second imaging device 700 is used to perform a second shooting action on the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and layered, in a horizontal direction, before the first imaging device 400 performs a first shooting action on the sample container 20, that is, the second imaging device 700 is used to shoot an image of the sample container 20 in a horizontal direction from the side of the sample container 20. The height direction of the sample container 20 is parallel to the vertical direction, and the imaging optical axis of the second imaging device 700 is perpendicular to the height direction of the sample container 20, so that it is convenient for the control device 500 to accurately obtain the total liquid level of the blood sample 30 and the height of the lower layer of liquid 33 according to the image captured by the second imaging device 700.

[0238] As an embodiment, the second camera device 700 performs the second shooting action on the sample container 20, including: the second camera device 700 directly shoots the image of the sample container 20 from the side of the sample container 20 or indirectly shoots the image of the sample container 20 through the second reflector 102. That is, the second camera device 700 is used to directly or indirectly shoot the image of the sample container 20 and / or the blood sample 30 in the sample container 20.

[0239] Reference Figure 2 and Figure 7 As shown, as an embodiment, the camera device further includes a second reflector 102, and the second reflector 102 is used to: when the second camera device 700 performs the second shooting action, at least an image showing the whole image of the sample container 20 in a two-dimensional form and / or a three-dimensional form is reflected to the second camera device 700. The second camera device 700 performs the second shooting action on the sample container 20, including: the second camera device 700 indirectly captures the image of the sample container 20 through the second reflector 102. Of course, in specific applications, the sample analysis device 10 may also not be provided with the second reflector 102, for example, refer to Figure 8 As shown, as an alternative implementation, the second imaging device 700 performs a second photographing action on the sample container 20 , including: the second imaging device 700 directly photographs the image of the sample container 20 from the side of the sample container 20 .

[0240] As an implementation manner, the second imaging device 700 is a second camera, and the sample analysis device 10 further includes a second fill light component 103. The second camera captures the full view of the blood sample 30 from the side of the sample container 20. The second fill light component 103 is mainly used to fill light for the full view of the blood sample 30 in the field of view of the second camera, so as to at least illuminate all the blood samples 30 in the sample container 20.

[0241] As an embodiment, the control device 500 is further configured to: before acquiring the first target image 1012d, first control the second camera device 700 to perform a second shooting action on the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and layered, obtain the height position of the interface liquid surface 321 or the interface liquid layer according to the image captured by the second camera device 700 in the second shooting action, and obtain the target height position according to the height position of the interface liquid surface 321 or the interface liquid layer. Obtain the first target image 1012d according to the information fed back by the first camera device 400 in the first shooting action, including: controlling one of the sample container 20 and the first camera device 400 to move relative to the other and stop at the target height position, controlling the first camera device 400 to perform the first shooting action on the sample container 20, and obtaining the first target image 1012d according to the image captured by the first camera device 400 in the first shooting action. The target height position can be a specific height position or a height range value. Since the first camera device has requirements for the focus position when performing the shooting action of the white film layer, before performing the shooting action of the white film layer, the height position of the interface liquid surface 321 or the interface liquid layer is first found, and then the shooting action of the white film layer is performed based on the height position, which is beneficial to ensure the clarity of the image of the interface liquid surface 321 or the interface liquid layer.

[0242] Reference Figure 2 , Figure 3 and Figure 5 As shown, as an embodiment, the sample analysis device 10 further includes a sample management device 100 and a sample container transmission device 300; the sample management device 100 is at least used for placing the sample container 20 loaded with the blood sample 30 to achieve the loading of the blood sample 30; the sample container transmission device 300 is used to transmit the sample container 20 loaded with the blood sample 30 from the sample management device 100 to the sample measurement device 200. The sample management device 100 can be used to achieve the loading function of the blood sample 30, and the sample container 20 loaded with the blood sample 30 can be placed in the sample management device 100 by an operator or an operating robot. The sample container transmission device 300 can be used to achieve the sample transmission function.

[0243] Reference Figure 2 , Figure 3 and Figure 5 As shown, as an embodiment, the sample container transmission device 300 includes a conveying track 310, a first sample container scheduling mechanism 320 and a sample container transfer device 330, the conveying track 310 is used to convey a sample seat having a single first container position, the first container position is used to place a single sample container 20; the first sample scheduling mechanism is used to schedule the sample container 20 placed in the sample management device 100 and loaded with a blood sample 30 to the sample seat located on the conveying track 310.

[0244] Reference Figure 2 and Figure 3 As shown, as an embodiment, the sample container transfer device 330 is arranged between the conveying track 310 and the sample measuring device 200, so as to grab the sample containers 20 on the sample holder conveyed by the conveying track 310 one by one to the sample rack inside the sample container transfer device 330, and then send the sample containers 20 to the sample measuring device 200 through the sample rack for measurement. The conveying track 310 is the main conveying track 310 of the sample analysis device 10, and the sample measuring device 200 is a sample processing device in the sample analysis device 10 for performing an analysis function on the blood sample 30. The sample container transfer device 330 is also called an RBU module, which is mainly used to grab the sample containers 20 on the sample holder conveyed by the conveying track 310 one by one to the sample rack inside the sample container transfer device 330, and then send the sample containers 20 to the sample measuring device 200 through the sample rack for measurement. In this embodiment, by setting up the sample container transfer device 330, the effect of transferring the sample container 20 from the sample seat to the sample rack for transmission is achieved, so that the blood sample 30 transmission function between the conveying track 310 with the sample seat conveying function and the sample measuring device 200 with the sample rack conveying function can be realized without changing the structure of the conveying track 310 and the sample measuring device 200.

[0245] As an embodiment, the sample container transfer device 330 includes a sample seat scheduling mechanism, a second sample container scheduling mechanism and a sample rack scheduling mechanism. The sample seat scheduling mechanism is at least used to transfer the sample seat transferred by the conveying track 310 to the sample container transfer device 330 to the rack position. The second sample container scheduling mechanism is used to schedule the sample container 20 on the sample seat at the rack position to the sample rack provided by the sample rack scheduling mechanism. The sample rack has at least two second container positions, each of which is used to place a single sample container 20. The sample rack scheduling mechanism is used to schedule the sample rack loaded with the sample container 20 and the blood sample 30 in the sample container 20 to the sample measurement device 200. The sample seat is a transmission carrier of a single sample container 20, and the sample rack is a transmission carrier of multiple sample containers 20. The sample seat scheduling mechanism is used to realize the connection between the sample container transfer device 330 and the conveying track 310 on the one hand, and to realize the transmission of the sample seat in the sample container transfer device 330 on the other hand. The sample rack scheduling mechanism is used to realize the connection between the sample container transfer device 330 and the sample measurement device 200, and to realize the transfer of the sample rack in the sample container transfer device 330. The second sample container scheduling mechanism is used to realize the interaction between the sample seat scheduling mechanism and the sample rack scheduling mechanism, and to realize the transfer of the sample container 20 between the sample seat and the sample rack.

[0246] Reference Figure 2 , Figure 3 and Figure 5 As shown, as an embodiment, the sample analysis device 10 further includes a centrifugal device 900. The centrifugal device 900 is used to centrifuge the sample container 20 loaded with the blood sample 30 so that the blood sample 30 is centrifugally layered into an upper layer of liquid 31, an intermediate layer of liquid 32, and a lower layer of liquid 33. The sample management device 100 is used to allow the sample container 20 loaded with the blood sample 30 and not subjected to the centrifugal operation to be placed therein so as to load the uncentrifuged blood sample 30, and to allow the sample container 20 loaded with the blood sample 30 and subjected to the centrifugal operation to be placed therein so as to load the centrifuged blood sample 30. The sample container transfer device 300 is at least used to transfer the sample container 20 outputted from the sample management device 100 and loaded with the uncentrifuged blood sample 30 to the centrifugal device 900 for centrifugation, to transfer the sample container 20 outputted from the centrifugal device 900 and loaded with the centrifuged blood sample 30 to the sample measurement device 200, and to transfer the sample container 20 outputted from the sample management device 100 and loaded with the centrifuged blood sample 30 to the sample measurement device 200. In this embodiment, the sample analysis device 10 has the function of centrifuging the blood sample 30, which can meet the sample loading and measurement requirements of uncentrifuged samples and centrifuged samples. Of course, in specific applications, as an alternative implementation, the sample analysis device 10 is also possible without the centrifugation device 900, and the blood sample 30 is placed on the sample analysis device 10 for measurement after the centrifugation of other devices is completed.

[0247] Reference Figure 2 and Figure 5 As shown in the figure, as an implementation of the location of the first imaging device 400, the first imaging device 400 is used to perform a first photographing action on the sample container 20 transferred to the first photographing position by the sample container transfer device 330. The first photographing position is located in the sample container transfer device 330. The first photographing position is located on the path of the sample container transfer device 330 to transfer the sample container 20 and is located between the conveying track 310 and the sample measuring device 200. In this implementation, the first imaging device 400 is provided in the sample container transfer device 330 (i.e., the RBU module) to perform a first photographing action on the sample container 20 in the sample container transfer device 330.

[0248] Reference Figure 3 and Figure 5As shown, as another embodiment of the position of the first imaging device 400, the first imaging device 400 is used to perform a first photographing action on the sample container 20 transported by the conveying track 310 to the first photographing position, and the first photographing position is located on the conveying track 310. The first photographing position is located on the path of the conveying track 310 for transporting the sample container 20 and is located between the first sample scheduling mechanism and the sample container transfer device 330. In this alternative embodiment, the first imaging device 400 is disposed on the conveying track 310 to perform a first photographing action on the sample container 20 on the conveying track 310.

[0249] Reference Figure 4 and Figure 5 As shown in FIG. 1 , as another embodiment of the position of the first imaging device 400, the first imaging device 400 is used to perform a first photographing action on the sample container 20 transported by the sample measuring device 200 to the first photographing position, and the first photographing position is located in the sample measuring device 200. The first photographing position is located on the path of the sample measuring device 200 transporting the sample container 20 and is located before the sample suction position of the sample measuring device 200. In this alternative embodiment, the first imaging device 400 is provided in the sample measuring device 200 to perform a first photographing action on the sample container 20 before the sample is sucked in the sample measuring device 200. Furthermore, a sample suction channel 210 for transporting a sample rack is provided in the sample measuring device 200, and the first photographing position and the sample suction position are arranged at intervals in the sample suction channel 210.

[0250] Reference Figure 3 and Figure 5As shown, as another embodiment of the setting position of the first camera device 400, in a scenario where the sample analysis equipment 10 includes a centrifuge 900, the first camera device 400 is used to perform a first shooting action on the sample container 20 transported by the sample container transmission device 300 to the first shooting position. The first shooting position is set on the path where the sample container transmission device 300 transports the sample container 20 from the sample management device 100 to the sample measurement device 200 and is located between the centrifuge 900 and the sample measurement device 200. Of course, in the scenario where the sample analysis equipment 10 includes a centrifuge 900, the setting position of the first camera device 400 is not limited thereto. For example, the first camera device 400 can also be used to perform a first shooting action on a sample container 20 that is transported by the sample measuring device 200 to the first shooting position. The first shooting position is located in the sample measuring device 200. The first shooting position is located on the path for the sample measuring device 200 to transport the sample container 20 and is located before the sample suction position of the sample measuring device 200. Alternatively, the first camera device 400 can also be used to perform a first shooting action on a sample container 20 that is transferred from a sample container transfer device 330 to the first shooting position. The first shooting position is located in the sample container transfer device 330. The first shooting position is located on the path for the sample container transfer device 330 to transfer the sample container 20 and is located between the conveying track 310 and the sample measuring device 200.

[0251] Reference Figure 2 , Figure 3 and Figure 5 As shown, as an embodiment, the second camera device 700 is used to perform a second shooting action on the sample container 20 transported by the conveying track 310 to the second shooting position, and the second shooting position is located on the conveying track 310. The second shooting position is arranged on the path of the conveying track 310 to transport the sample container 20 and is located between the first sample scheduling mechanism and the sample container transfer device 330.

[0252] As an implementation manner, the second photographing position is located between the centrifugal device 900 and the sample measuring device 200 .

[0253] As an implementation manner, the second shooting position is located between the centrifugal device 900 and the sample container transfer device 330 .

[0254] As an implementation manner, the second imaging device 700 is disposed in the sample container transport device 300 and is located beside the centrifugal device 900 .

[0255] As an embodiment, before controlling the display device 101 to display information characterizing the hematocrit test result of the blood sample 30 in the sample container 20 on the first interface 1012, the control device 500 is further configured to obtain the hematocrit test result of the blood sample 30 in the sample container 20 based on the second target image 1012e captured by the second camera device 700 performing the second shooting action.

[0256] As an embodiment, before controlling the display device 101 to display information used to characterize the liquid volume detection result of the blood sample 30 in the sample container 20 on the first interface 1012, the control device 500 is also configured to: obtain the liquid volume detection result of the blood sample 30 in the sample container 20 according to the second target image 1012e captured by the second camera device 700 performing the second shooting action.

[0257] As an embodiment, before controlling the display device 101 to display the HIL detection result of the blood sample 30 in the sample container 20 on the first interface 1012, the control device 500 is also configured to: obtain the HIL detection result of the blood sample 30 in the sample container 20 according to the second target image 1012e captured by the second camera device 700 performing the second shooting action.

[0258] As an embodiment, the sample analysis device 10 is a sample analysis pipeline or a sample analysis cascade system. The sample analysis device 10 also includes a sample management device 100 and a sample container transmission device 300. The sample management device 100 is at least used to place a sample container 20 loaded with a blood sample 30 to achieve the loading of the blood sample 30. The sample container transmission device 300 is used to transmit the sample container 20 loaded with the blood sample 30 from the sample management device 100 to the sample measurement device 200; the display device 101 includes a first display screen 1011, and the first display screen 1011 is located next to the sample management device 100 or next to the sample container transmission device 300. The first display screen 1011 is used to display a first interface 1012, storage information of the blood sample 30 in the sample management device 100, and information of the blood sample 30 transmitted by the sample container transmission device 300. The sample analysis device 10 includes at least two sample measurement devices 200, and the at least two sample measurement devices 200 can be connected to the same sample container transfer device 330, or respectively connected to two independent sample container transfer devices 330. The first display screen 1011 is a display screen at the operation end of the sample analysis pipeline or the sample analysis cascade system. In this embodiment, the first interface 1012 is set to be displayed on the first display screen 1011, so that the operator can more conveniently find the quality detection information of the blood sample 30.

[0259] Of course, in specific applications, as an alternative implementation, the first interface 1012 can also be displayed on other display screens. For example, when the sample analysis device 10 is a sample analysis pipeline or a sample analysis cascade system or a single sample analyzer, the display device 101 includes a second display screen provided on the sample measurement device 200. The second display screen is used to display at least the first interface 1012 and the measurement item information of the blood sample 30 in the sample measurement device 200. The second display screen is a display screen provided by the sample measurement device 200, that is, a display screen of the single sample analyzer.

[0260] As an implementation manner, the control device 500 is further configured to transmit the information displayed on the first interface 1012 to a laboratory information management system (ie, LIS system) that is communicatively connected to the sample analysis device 10 .

[0261] As an embodiment, the sample measuring device 200 includes a sample dispensing mechanism, a reagent dispensing mechanism, an incubation mechanism and a measuring mechanism. The sample dispensing mechanism is used to draw a blood sample 30 from the sample container 20 and distribute at least a portion of the drawn blood sample 30 to a reaction container. The reagent dispensing mechanism is used to draw a reagent from a reagent container and distribute at least a portion of the drawn reagent to a reaction container. The incubation mechanism is used to incubate the blood sample 30 or a mixture of the sample and the reagent in the reaction container. The measuring mechanism is used to measure a reaction solution made of the blood sample 30 and the reagent in the reaction container.

[0262] As an embodiment, the sample dispensing mechanism includes a sample needle, a first suction and discharge driving component, and a first motion driving component; the sample needle is used to absorb and discharge the sample. The first suction and discharge driving component is used to provide driving force for the sample needle to absorb and discharge the sample. The first motion driving component is used to drive the sample needle to move in two-dimensional or three-dimensional space, so that the sample needle moves to different positions, such as a standby position, a sample suction position, a sample addition position, a cleaning position, etc.

[0263] As an embodiment, the first suction and discharge driving component is a syringe. Of course, in specific applications, the configuration of the first suction and discharge driving component is not limited thereto, and for example, it can also be a pump or a positive and negative pressure driving component.

[0264] As an embodiment, the sample measuring device 200 also includes a reaction container supply mechanism and a reaction container transfer mechanism, the reaction container supply mechanism is used to provide reaction containers; the reaction container transfer mechanism is used to transfer reaction containers. In the specific measuring process, the sample distribution mechanism distributes the blood sample 30 to the reaction container supplied by the reaction container supply mechanism, the reaction container transfer mechanism transfers the reaction container provided by the reaction container supply mechanism and completed with the sample to the incubation mechanism, the reagent distribution mechanism distributes the reagent in the reaction container, the measuring mechanism measures the reaction made by the blood sample 30 and the reagent in the reaction container, and the reaction container transfer mechanism discards and recycles the reaction container after the measurement is completed. In this embodiment, the reaction container is a disposable container, that is, the reaction container is discarded and recycled after carrying the blood sample 30 to complete the measurement of the corresponding measurement item, without the need for cleaning and reuse in the sample measuring device 200, thereby simplifying the structure and working procedures of the sample measuring device 200. Of course, in specific applications, the sample measuring device 200 can also use a recycled reaction container.

[0265] As an embodiment, the sample measuring device 200 is used to perform coagulation-related detection items on the upper layer liquid 31 distributed into the reaction container. The sample measuring device 200 is a coagulation analyzer, and the reagent dispensing mechanism includes a mixed reagent dispensing component and a trigger reagent dispensing component. The mixed reagent dispensing component is used to draw mixed reagent from the mixed reagent container and distribute it to the reaction container, and the trigger reagent dispensing component is used to draw trigger reagent from the trigger reagent container and distribute it to the reaction container. Each coagulation detection item includes at least a sample loading period, an incubation period, a trigger reagent period and a measurement period that are performed in sequence. Among them, during the sample loading period, the sample dispensing mechanism draws blood sample 30 from the sample container 20 and distributes it to the reaction container to complete the sample loading operation. During the incubation period of the multi-reagent coagulation measurement item, the mixed reagent dispensing component draws mixed reagent from the reagent container and distributes it to the reaction container, and the incubation mechanism incubates the reaction container loaded with at least blood sample 30 and mixed reagent to complete the incubation operation of the multi-reagent coagulation measurement item. During the incubation period of the single-reagent coagulation assay, the incubation mechanism incubates the reaction container loaded with at least the blood sample 30 to complete the incubation operation of the single-reagent coagulation assay. During the trigger reagent period, the trigger reagent dispensing component draws the trigger reagent from the reagent container and distributes it to the reaction container, and mixes the reaction container to complete the trigger reagent addition operation. During the measurement period, the measurement mechanism measures the reaction liquid in the reaction container to complete the measurement operation. Of course, in specific applications, the sample measurement device 200 is not limited to a coagulation analyzer. For example, as an alternative embodiment, the sample measurement device 200 can also be a biochemical analyzer, an immunoassay analyzer, etc.

[0266] As an embodiment, the processing process of the blood sample 30 used in the determination of coagulation items includes: using sodium citrate as an anticoagulant, mixing the anticoagulant and the blood sample 30 thoroughly, and then centrifuging on a centrifuge 900; due to the different densities of red blood cells, white blood cells, platelets and plasma, the blood sample 30 after centrifugation is divided into three layers, the bottom layer is mainly red blood cells; the top layer is plasma, which is light yellow; between the red blood cells and plasma is a white film layer, the main components of which are white blood cells and platelets; the determination of coagulation items mainly involves the absorption and analysis of the plasma above, and the plasma used for the determination of coagulation items is also called platelet-poor plasma.

[0267] In a preferred embodiment, the sample analysis device 10 mainly adopts an optical photography method to take photos of the whole image and the white film layer of the centrifuged blood sample 30, and uses the whole image information of the blood sample 30 to calculate the liquid volume detection result, HCT detection result and HIL detection result of the blood sample 30, and uses the white film layer photography method to obtain the clot detection result of the blood sample 30. The liquid volume detection result, HCT detection result, HIL detection result, clot detection result, the whole image of the centrifuged blood sample 30, and the white film layer image are displayed on the same interface. In this way, in a specific application, the operator can view the white film layer image, the sample whole image, the HCT detection result, the clot detection result, the liquid volume detection result and the HIL detection result of the same blood sample 30 through the same interface, and obtain comprehensive sample quality verification information, which greatly improves the efficiency and intuitiveness of the quality verification of the blood sample 30.

[0268] The second aspect of the embodiment of the present invention provides a sample analysis device 10, which differs from the sample analysis device 10 provided in the first aspect of the embodiment of the present invention mainly in that: the first aspect focuses on limiting the content displayed by the first target image 1012d and the second target image 1012e; while the second aspect focuses on limiting the functional role displayed by the first target image 1012d and the second target image 1012e.

[0269] Specifically, the sample analysis device 10 provided in the second aspect of the embodiment of the present invention includes a sample measuring device 200, a camera device, a display device 101, and a control device 500. The sample measuring device 200 is used to absorb at least part of the upper layer liquid 31 from the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper layer liquid 31, the middle layer liquid 32, and the lower layer liquid 33, and distribute it to the reaction container for measurement, wherein the middle layer liquid 32 at least contains platelets and / or leukocytes. The camera device is used to photograph the sample container 20 loaded with the blood sample 30 and after the blood sample 30 is centrifuged and separated into the upper layer liquid 31, the middle layer liquid 32, and the lower layer liquid 33 before the sample measuring device 200 absorbs the upper layer liquid 31 from the sample container 20. The display device 101 is used to display a first interface 1012, and the first interface 1012 is used to display a first target image 1012d obtained by photographing the sample container 20 by the camera device, and display at least one of a second target image 1012e obtained by photographing the sample container 20 by the camera device, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. The control device 500 is configured to: in response to a trigger instruction, control the display device 101 to display the first interface 1012. The first target image 1012d is used as a basis for at least one of the following: for the operator to determine whether there is a clot in the intermediate layer liquid 32, for the operator to determine the degree of coagulation of the blood sample 30, and for the operator to review whether the information displayed on the first interface 1012 for characterizing the clot detection result of the blood sample 30 in the sample container 20 is accurate; the second target image 1012e is used as a basis for at least one of the following: for the operator to review whether the information displayed on the first interface 1012 for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 is accurate, The operator is provided to review whether the information in the first interface 1012 used to characterize the liquid volume test result of the blood sample 30 in the sample container 20 is accurate, the operator is provided to review whether the information in the first interface 1012 used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 is accurate, the operator is provided to review whether the information in the first interface 1012 used to characterize the jaundice test result of the blood sample 30 in the sample container 20 is accurate, and the operator is provided to review whether the information in the first interface 1012 used to characterize the lipemia test result of the blood sample 30 in the sample container 20 is accurate.

[0270] As an embodiment, the first interface 1012 is used to display a first target image 1012d and a second target image 1012e, as well as to display at least one of information used to characterize a hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize a clot test result of the blood sample 30 in the sample container 20, information used to characterize a liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize a hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize a jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize a lipemia test result of the blood sample 30 in the sample container 20.

[0271] As an embodiment, the first interface 1012 is used to display a first target image 1012d, a second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0272] As an embodiment, the first interface 1012 includes a first display area 1012a, a second display area 1012b and a third display area 1012c, the first display area 1012a is used to display a first target image 1012d; the second display area 1012b is used to display a second target image 1012e; the third display area 1012c is used to display at least one of information characterizing a hematocrit test result of the blood sample 30 in the sample container 20, information characterizing a clot test result of the blood sample 30 in the sample container 20, information characterizing a liquid volume test result of the blood sample 30 in the sample container 20, information characterizing a hemolysis test result of the blood sample 30 in the sample container 20, information characterizing a jaundice test result of the blood sample 30 in the sample container 20, and information characterizing a lipemia test result of the blood sample 30 in the sample container 20.

[0273] As an embodiment, the first display area 1012a, the second display area 1012b and the third display area 1012c are distributed in the following distribution manner: the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged and distributed along the first direction X; the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged and distributed along the second direction Y; two of the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged and distributed along the first direction X, and the area formed by the two and the other are arranged and distributed along the second direction Y; two of the first display area 1012a, the second display area 1012b and the third display area 1012c are arranged and distributed along the second direction Y, and the area formed by the two and the other are arranged and distributed along the first direction X; wherein the first direction X and the second direction Y are perpendicular to each other.

[0274] In addition to the above, other parts and principles of the sample analysis device 10 provided in the second aspect of the embodiment of the present invention can refer to the above first aspect and will not be described in detail here.

[0275] According to a third aspect of an embodiment of the present invention, there is provided a control method for a sample analysis device 10, the control method comprising: controlling a display device 101 to display a second interface; in response to a trigger instruction formed by an operator viewing a blood sample 30 in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device 101 to display a first interface 1012; wherein the first interface 1012 displays a first target image 1012d obtained by photographing a sample container 20 loaded with a blood sample 30 and after the blood sample 30 is centrifugally stratified into an upper layer of liquid 31, an intermediate layer of liquid 32, and a lower layer of liquid 33 by a camera device, and displays a second target image 1012e obtained by photographing the sample container 20 by the camera device, information for characterizing a hematocrit test result of the blood sample 30 in the sample container 20, information for characterizing a clot test result of the blood sample 30 in the sample container 20, information for characterizing a liquid volume test result of the blood sample 30 in the sample container 20, information for characterizing a hemolysis test result of the blood sample 30 in the sample container 20, and information for characterizing a blood volume test result of the blood sample 30 in the sample container 20. The first target image 1012d at least includes an image showing the interface liquid surface 321 or the interface liquid layer in a two-dimensional form and / or a three-dimensional form; the second target image 1012e at least includes an image showing the entire height of at least one side of the sample container 20 in a two-dimensional form and / or a three-dimensional form. The image may include at least one side of the entire blood sample 30 in the sample container 20 in a two-dimensional and / or three-dimensional form, or at least an image of the liquid surface of the upper liquid 31, the liquid surface of the middle liquid 32 and the liquid surface of the lower liquid 33 in the sample container, or at least an image of at least one side of the entire upper liquid 31, the entire middle liquid 32 and the entire lower liquid 33 in the sample container 20 in a two-dimensional and / or three-dimensional form, or at least an image of at least one side of the bottom, middle part and top of the sample container 20 in a two-dimensional and / or three-dimensional form.

[0276] As an embodiment, the above-mentioned control of the display device 101 to display the first interface 1012 includes: controlling the display device 101 to display the first interface 1012 in a local area of ​​the second interface in a pop-up window. Alternatively, the above-mentioned control of the display device 101 to display the first interface 1012 includes: controlling the display device 101 to switch from displaying the second interface to displaying the first interface 1012 in a switching form.

[0277] As an embodiment, the first interface 1012 displays a first target image 1012d and a second target image 1012e, and displays at least one of information used to characterize a hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize a clot test result of the blood sample 30 in the sample container 20, information used to characterize a liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize a hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize a jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize a lipemia test result of the blood sample 30 in the sample container 20.

[0278] As an embodiment, the first interface 1012 displays a first target image 1012d, a second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0279] In addition to the above, other parts and principles of the control method of the sample analysis device 10 provided in the third aspect of the embodiment of the present invention can refer to the first aspect mentioned above and will not be described in detail here.

[0280] The fourth aspect of an embodiment of the present invention provides a control method for a sample analysis device 10. The difference between the control method of the sample analysis device 10 and the sample analysis device 10 provided in the third aspect of the above-mentioned embodiment of the present invention mainly lies in that: the above-mentioned third aspect focuses on limiting the content displayed by the first target image 1012d and the second target image 1012e; while the fourth aspect focuses on limiting the functional role displayed by the first target image 1012d and the second target image 1012e.

[0281] Specifically, the control method of the sample analysis device 10 provided in the fourth aspect of the embodiment of the present invention includes: controlling the display device 101 to display the second interface; in response to a trigger instruction formed by an operator viewing a blood sample 30 in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device 101 to display the first interface 1012; wherein the first interface 1012 displays a first target image 1 obtained by a camera device photographing a sample container 20 loaded with a blood sample 30 and after the blood sample 30 is centrifuged and separated into an upper layer of liquid 31, a middle layer of liquid 32, and a lower layer of liquid 33. 012d, and displaying at least one of the second target image 1012e obtained by photographing the sample container 20 by the camera device, the information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, the information used to characterize the clot test result of the blood sample 30 in the sample container 20, the information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, the information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, the information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and the information used to characterize the lipemia test result of the blood sample 30 in the sample container 20. The first target image 1012d is used as a basis for at least one of the following: for the operator to determine whether there is a clot in the intermediate layer liquid 32, for the operator to determine the degree of coagulation of the blood sample 30, and for the operator to review whether the information displayed on the first interface 1012 for characterizing the clot detection result of the blood sample 30 in the sample container 20 is accurate; the second target image 1012e is used as a basis for at least one of the following: for the operator to review whether the information displayed on the first interface 1012 for characterizing the hematocrit detection result of the blood sample 30 in the sample container 20 is accurate, and for the operator The operator reviews whether the information in the first interface 1012 used to characterize the liquid volume test result of the blood sample 30 in the sample container 20 is accurate, the operator reviews whether the information in the first interface 1012 used to characterize the hemolysis test result of the blood sample 30 in the sample container 20 is accurate, the operator reviews whether the information in the first interface 1012 used to characterize the jaundice test result of the blood sample 30 in the sample container 20 is accurate, and the operator reviews whether the information in the first interface 1012 used to characterize the lipemia test result of the blood sample 30 in the sample container 20 is accurate.

[0282] As an embodiment, the first interface 1012 displays a first target image 1012d and a second target image 1012e, and displays at least one of information used to characterize a hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize a clot test result of the blood sample 30 in the sample container 20, information used to characterize a liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize a hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize a jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize a lipemia test result of the blood sample 30 in the sample container 20.

[0283] As an embodiment, the first interface 1012 displays a first target image 1012d, a second target image 1012e, information used to characterize the hematocrit test result of the blood sample 30 in the sample container 20, information used to characterize the clot test result of the blood sample 30 in the sample container 20, information used to characterize the liquid volume test result of the blood sample 30 in the sample container 20, information used to characterize the hemolysis test result of the blood sample 30 in the sample container 20, information used to characterize the jaundice test result of the blood sample 30 in the sample container 20, and information used to characterize the lipemia test result of the blood sample 30 in the sample container 20.

[0284] In addition to the above, other parts and principles of the control method of the sample analysis device 10 provided in the fourth aspect of the embodiment of the present invention can refer to the above first to third aspects and will not be described in detail here.

[0285] The above description is only a preferred embodiment of the present invention, and does not limit the patent scope of the present invention. All equivalent structural changes made by using the contents of the present invention specification and drawings under the inventive concept of the present invention, or directly / indirectly applied in other related technical fields are included in the patent protection scope of the present invention.

Claims

1. A sample analysis device, characterized in that: include: A sample measuring device, the sample measuring device is used to draw at least part of the upper layer liquid from a sample container loaded with a blood sample and after the blood sample is centrifuged and separated into an upper layer liquid, a middle layer liquid, and a lower layer liquid, and distribute the upper layer liquid to a reaction container for measurement, wherein the middle layer liquid at least contains platelets and / or leukocytes; a camera device, the camera device being used to photograph the sample container loaded with the blood sample and after the blood sample is centrifuged and separated into the upper layer liquid, the middle layer liquid, and the lower layer liquid before the sample measuring device draws the upper layer liquid from the sample container; a display device, the display device being used to display a first interface, the first interface being used to display a first target image obtained by photographing the sample container by the camera device, and displaying at least one of a second target image obtained by photographing the sample container by the camera device, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; A control device, the control device being configured to: in response to a trigger instruction, control the display device to display the first interface; Wherein, there is a boundary liquid surface or boundary liquid layer between the intermediate layer liquid and the upper layer liquid; The first target image at least includes an image showing the interface liquid surface or the interface liquid layer in a two-dimensional form and / or a three-dimensional form; The second target image at least includes an image showing the entire height of at least one side of the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the entire blood sample in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing the liquid surface of the upper liquid layer, the liquid surface of the middle liquid layer, and the liquid surface of the lower liquid layer in the sample container, or at least includes an image showing at least one side of the entire upper liquid layer, the entire middle liquid layer, and the entire lower liquid layer in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the bottom, middle part, and top of the sample container in a two-dimensional and / or three-dimensional form.

2. The sample analysis device according to claim 1, characterized in that: The first interface is used to display at least the first target image and the second target image; Alternatively, the first interface is used to display at least the first target image and information used to characterize the clot detection result of the blood sample in the sample container; Alternatively, the first interface is used to display at least the first target image and information used to characterize a hematocrit test result of the blood sample in the sample container.

3. The sample analysis device according to claim 1, characterized in that: The first interface is used to display the first target image, and display at least two of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first interface is used to display the first target image and the second target image, and to display at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; Alternatively, the first interface is used to display the first target image and information for characterizing a clot detection result of the blood sample in the sample container, and display at least one of information for characterizing a hematocrit detection result of the blood sample in the sample container, information for characterizing a liquid volume detection result of the blood sample in the sample container, information for characterizing a hemolysis detection result of the blood sample in the sample container, information for characterizing a jaundice detection result of the blood sample in the sample container, and information for characterizing a lipemia detection result of the blood sample in the sample container; Alternatively, the first interface is used to display the first target image and information for characterizing a hematocrit test result of the blood sample in the sample container, and to display at least one of information for characterizing a liquid volume test result of the blood sample in the sample container, information for characterizing a hemolysis test result of the blood sample in the sample container, information for characterizing a jaundice test result of the blood sample in the sample container, and information for characterizing a lipemia test result of the blood sample in the sample container.

4. The sample analysis device according to claim 1, characterized in that: The first interface is used to display the first target image, and display at least three of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first interface is used to display at least the first target image, the second target image, information for characterizing a hematocrit test result of the blood sample in the sample container, and information for characterizing a clot test result of the blood sample in the sample container; Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize a clot detection result of the blood sample in the sample container, and information used to characterize a liquid volume detection result of the blood sample in the sample container; Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, and information used to characterize the liquid volume test result of the blood sample in the sample container; Alternatively, the first interface is used to display at least the first target image, information for characterizing a clot detection result of the blood sample in the sample container, information for characterizing a hematocrit detection result of the blood sample in the sample container, and information for characterizing a liquid volume detection result of the blood sample in the sample container; Alternatively, the first interface is at least used to display the first target image, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

5. The sample analysis device according to claim 1, characterized in that: The first interface is used to display the first target image, and at least four of the second target image, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first interface is used to display at least the first target image, the second target image, information for characterizing a hematocrit test result of the blood sample in the sample container, information for characterizing a clot test result of the blood sample in the sample container, and information for characterizing a liquid volume test result of the blood sample in the sample container; Alternatively, the first interface is used to display at least the first target image, the second target image, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container; or, Alternatively, the first interface is used to display the first target image, information for characterizing a hematocrit test result of the blood sample in the sample container, information for characterizing a clot test result of the blood sample in the sample container, information for characterizing a liquid volume test result of the blood sample in the sample container, information for characterizing a hemolysis test result of the blood sample in the sample container, information for characterizing a jaundice test result of the blood sample in the sample container, and information for characterizing a lipemia test result of the blood sample in the sample container; Alternatively, the first interface is used to display the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

6. The sample analysis device according to any one of claims 1 to 5, characterized in that: The first interface includes: A first display area, wherein the first display area is used to display the first target image; a second display area, wherein the second display area is used to display the second target image; a third display area, the third display area being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first display area, the second display area and the third display area are distributed in the following manner: The first display area, the second display area and the third display area are arranged and distributed along a first direction; The first display area, the second display area and the third display area are arranged and distributed along a second direction; Two of the first display area, the second display area and the third display area are arranged and distributed along a first direction, and an area formed by the two together with another one is arranged and distributed along a second direction; Two of the first display area, the second display area and the third display area are arranged and distributed along the second direction, and the area formed by the two together with the other one is arranged and distributed along the first direction; The first direction and the second direction are perpendicular to each other.

7. The sample analysis device according to claim 6, characterized in that: The first display area, the second display area and the third display area are arranged and distributed along the first direction, and the second display area is located between the first display area and the third display area; And / or, the third display area is used to display information characterizing the hematocrit test result of the blood sample in the sample container, information characterizing the clot test result of the blood sample in the sample container, information characterizing the liquid volume test result of the blood sample in the sample container, information characterizing the hemolysis test result of the blood sample in the sample container, information characterizing the jaundice test result of the blood sample in the sample container, and information characterizing the lipemia test result of the blood sample in the sample container.

8. The sample analysis device according to claim 1, characterized in that: The first interface includes: A first display area, wherein the first display area is used to display the first target image; a second display area, the second display area being used to display the second target image, or being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first display area and the second display area are arranged and distributed along a first direction; or, the first display area and the second display area are arranged and distributed along a second direction; wherein the first direction and the second direction are perpendicular to each other.

9. The sample analysis device according to any one of claims 1 to 5, characterized in that: The display device is also used to display a second interface, and the second interface is used to display management information of the blood sample; The trigger instruction includes: an instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input.

10. The sample analysis device according to claim 9, characterized in that: The controlling the display device to display the first interface includes: controlling the display device to display the first interface in a superimposed manner in a local area of ​​the second interface in a pop-up window; Alternatively, controlling the display device to display the first interface includes: controlling the display device to switch from displaying the second interface to displaying the first interface in a switching manner.

11. The sample analysis device according to any one of claims 1 to 5, characterized in that: The control device is further configured to: control the display device to mark at least one of the following information on the first interface: Information used to indicate that the hematocrit test result of the blood sample in the sample container is abnormal; Information used to indicate that a clot detection result of the blood sample in the sample container is abnormal; Information used to indicate that a result of a test on the amount of the blood sample in the sample container is abnormal; Information used to characterize that the hemolysis test result of the blood sample in the sample container is abnormal; Information used to indicate that the jaundice test result of the blood sample in the sample container is abnormal; Information used to characterize that the lipemia test result of the blood sample in the sample container is abnormal.

12. The sample analysis device according to any one of claims 1 to 5, characterized in that: The control device is further configured to: obtain information for characterizing a clot detection result of the blood sample in the sample container according to the first target image or according to the first target image and the second target image; And / or, the first target image is used as a basis for at least one of the following: for an operator to determine whether there is a clot in the intermediate layer liquid, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information in the first interface used to characterize the clot detection result of the blood sample in the sample container is accurate.

13. The sample analysis device according to any one of claims 1 to 5, characterized in that: The control device is further configured to obtain, according to the second target image, at least one of the following test result information: information for characterizing a hematocrit test result of the blood sample in the sample container, information for characterizing a liquid volume test result of the blood sample in the sample container, information for characterizing a hemolysis test result of the blood sample in the sample container, information for characterizing a jaundice test result of the blood sample in the sample container, and information for characterizing a lipemia test result of the blood sample in the sample container; And / or, the second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

14. The sample analysis device according to any one of claims 1 to 5, characterized in that: The control device is also configured to: According to the second target image, obtaining the total liquid level of the blood sample in the sample container and the height of the lower layer of liquid; According to the total liquid level, obtaining information for characterizing a liquid volume detection result of the blood sample in the sample container; Information for characterizing a hematocrit test result of the blood sample in the sample container is obtained according to the total liquid level and the height of the lower layer of liquid.

15. The sample analysis device according to claim 14, characterized in that: The obtaining, according to the total liquid level, information for characterizing the liquid volume detection result of the blood sample in the sample container comprises: obtaining information for characterizing the liquid volume detection result of the blood sample in the sample container according to the total liquid level and a conversion function pre-stored in the sample analysis device or obtained according to a conversion function calibration process, wherein the conversion function is a conversion relationship between the liquid level in the sample container and the volume of the blood sample; The obtaining, according to the total liquid level and the height of the lower layer liquid, information used to characterize the hematocrit test result of the blood sample in the sample container comprises: obtaining, according to the total liquid level, the height of the lower layer liquid and the conversion function, information used to characterize the hematocrit test result of the blood sample in the sample container; Alternatively, obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level includes: obtaining a conversion function corresponding to the type of the sample container and pre-stored in the sample analysis device or obtained according to a conversion function calibration process according to the type of the sample container, and obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level and the conversion function, wherein the conversion function is a conversion relationship between the liquid level in the sample container and the volume of the blood sample; The obtaining, according to the total liquid level and the height of the lower layer liquid, information used to characterize the hematocrit test result of the blood sample in the sample container comprises: obtaining, according to the total liquid level, the height of the lower layer liquid and the conversion function, information used to characterize the hematocrit test result of the blood sample in the sample container; Alternatively, obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level may include: obtaining a size parameter of the sample container according to an instruction input by an operator through a human-computer interaction device; obtaining information for characterizing a result of a liquid volume detection of the blood sample in the sample container according to the total liquid level and the size parameter; The obtaining, based on the total liquid level and the height of the lower layer liquid, of information used to characterize a hematocrit test result of the blood sample in the sample container comprises: obtaining, based on the total liquid level, the height of the lower layer liquid and the size parameter, information used to characterize a hematocrit test result of the blood sample in the sample container.

16. The sample analysis device according to any one of claims 1 to 5, characterized in that: The imaging device comprises a first imaging device and a second imaging device, wherein the first imaging device is used to perform a first photographing action on the sample container from an oblique upper side or an oblique lower side of the intermediate layer liquid loaded in the sample container before the sample measuring device absorbs the upper layer liquid from the sample container; The second imaging device is used to perform a second photographing action on the sample container before the sample measuring device absorbs the upper layer of liquid from the sample container; The control device is further configured to: obtain the first target image according to information fed back by the first imaging device when performing the first shooting action; and obtain the second target image according to information fed back by the second imaging device when performing the second shooting action; The second imaging device and the first imaging device are two independent imaging devices, or the second imaging device and the first imaging device are the same imaging device; Preferably, the first imaging device performing the first shooting action on the sample container includes: the first imaging device directly shoots the image of the sample container from obliquely above or below the intermediate layer of liquid or indirectly shoots the image through a first reflector.

17. The sample analysis device according to claim 16, characterized in that: The second imaging device is used for performing the second imaging action on the sample container along a horizontal direction before the first imaging device performs the first imaging action on the sample container, in which the blood sample is loaded and after the blood sample is centrifuged and layered; The control device is further configured to: before acquiring the first target image, first control the second imaging device to perform the second shooting action on the sample container loaded with the blood sample and after the blood sample is centrifuged and layered, obtain the height position of the interface liquid surface or the interface liquid layer according to the image captured by the second imaging device when performing the second shooting action, and obtain the target height position according to the height position of the interface liquid surface or the interface liquid layer; The first target image is obtained based on information fed back from the first imaging device executing the first shooting action, including: controlling one of the sample container and the first imaging device to move relative to the other and stop at the target height position, controlling the first imaging device to execute the first shooting action on the sample container, and obtaining the first target image based on an image captured by the first imaging device executing the first shooting action.

18. The sample analysis device according to claim 16 or 17, characterized in that: The sample analysis device also includes a sample management device and a sample container transmission device; The sample management device is at least used for placing a sample container loaded with a blood sample to achieve the loading of the blood sample; The sample container transfer device is used to transfer the sample container loaded with the blood sample from the sample management device to the sample measurement device; The sample container transmission device comprises a conveying track, a first sample container scheduling mechanism and a sample container transfer device, wherein the conveying track is used to convey a sample seat having a single first container position, wherein the first container position is used to place a single sample container; The first sample scheduling mechanism is used to schedule the sample container placed in the sample management device and loaded with the blood sample to the sample seat located on the conveying track; The sample container transfer device comprises a sample seat scheduling mechanism, a second sample container scheduling mechanism and a sample rack scheduling mechanism, wherein the sample seat scheduling mechanism is at least used to transport the sample seat transported by the transport track to the sample container transfer device to a rack position, and the second sample container scheduling mechanism is used to schedule the sample container on the sample seat at the rack position to a sample rack provided by the sample rack scheduling mechanism, wherein the sample rack has at least two second container positions, each of which is used to place a single sample container; the sample rack scheduling mechanism is used to schedule the sample rack loaded with sample containers and blood samples in the sample containers to the sample measurement device; The first imaging device is used to perform the first photographing action on the sample container transferred by the sample container transfer device to the first photographing position, the first photographing position is located in the sample container transfer device, the first photographing position is set on the path of the sample container transferred by the sample container transfer device and is located between the conveying track and the sample measuring device; Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the transport track to the first photographing position, the first photographing position is located on the transport track, the first photographing position is arranged on the path of the transport track transporting the sample container and is located between the first sample scheduling mechanism and the sample container transfer device; Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the sample measuring device to the first photographing position, and the first photographing position is located in the sample measuring device. The first photographing position is set on the path of the sample measuring device for transporting the sample container and is located before the sample suction position of the sample measuring device.

19. The sample analysis device according to claim 16 or 17, characterized in that: The sample analysis device also includes a sample management device, a sample container transmission device and a centrifugal device; The centrifugal device is used to centrifuge the sample container loaded with the blood sample so that the blood sample is centrifugally separated into the upper layer of liquid, the middle layer of liquid, and the lower layer of liquid; The sample management device is used for placing a sample container loaded with a blood sample and not subjected to a centrifugal operation to achieve the loading of the uncentrifuged blood sample, and for placing a sample container loaded with a blood sample and subjected to a centrifugal operation to achieve the loading of the centrifuged blood sample; The sample container transfer device is at least used to transfer the sample container output from the sample management device and loaded with an uncentrifuged blood sample to the centrifuge device for centrifugation, to transfer the sample container output from the centrifuge device and loaded with a centrifuged blood sample to the sample measurement device, and to transfer the sample container output from the sample management device and loaded with a centrifuged blood sample to the sample measurement device; The first imaging device is used to perform the first photographing action on the sample container transported by the sample container transport device to the first photographing position, and the first photographing position is provided on the path where the sample container transport device transports the sample container from the sample management device to the sample measurement device and is located between the centrifuge device and the sample measurement device; Alternatively, the first imaging device is used to perform the first photographing action on the sample container transported by the sample measuring device to the first photographing position, and the first photographing position is located in the sample measuring device. The first photographing position is set on the path of the sample measuring device for transporting the sample container and is located before the sample suction position of the sample measuring device.

20. The sample analysis device according to any one of claims 1 to 5, characterized in that: The sample analysis device is a sample analysis pipeline or a sample analysis cascade system, and the sample analysis device also includes a sample management device and a sample container transmission device, the sample management device is at least used for placing a sample container loaded with a blood sample to achieve blood sample loading, and the sample container transmission device is used to transmit the sample container loaded with a blood sample from the sample management device to the sample measurement device; the display device includes a first display screen, the first display screen is located next to the sample management device or next to the sample container transmission device, and the first display screen is used to display the first interface, the storage information of the blood sample in the sample management device, and the information of the blood sample transmitted by the sample container transmission device; or, The sample analysis equipment is a sample analysis pipeline or a sample analysis cascade system or a single sample analyzer. The display device includes a second display screen provided on the sample measurement device. The second display screen is at least used to display the first interface and measurement item information of the blood sample in the sample measurement device.

21. A sample analysis device, characterized in that: include: A sample measuring device, the sample measuring device is used to draw at least part of the upper layer liquid from a sample container loaded with a blood sample and after the blood sample is centrifuged and separated into an upper layer liquid, a middle layer liquid, and a lower layer liquid, and distribute the upper layer liquid to a reaction container for measurement, wherein the middle layer liquid at least contains platelets and / or leukocytes; a camera device, the camera device being used to photograph the sample container loaded with the blood sample and after the blood sample is centrifuged and separated into the upper layer liquid, the middle layer liquid, and the lower layer liquid before the sample measuring device draws the upper layer liquid from the sample container; a display device, the display device being used to display a first interface, the first interface being used to display a first target image obtained by photographing the sample container by the camera device, and displaying at least one of a second target image obtained by photographing the sample container by the camera device, information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; A control device, the control device being configured to: in response to a trigger instruction, control the display device to display the first interface; The first target image is used as a basis for at least one of the following: for an operator to determine whether the intermediate layer of liquid has a clot, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information displayed in the first interface for characterizing the clot detection result of the blood sample in the sample container is accurate; The second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

22. The sample analysis device according to claim 21, characterized in that: The first interface is used to display the first target image and the second target image, and to display at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; Preferably, the first interface is used to display the first target image, the second target image, information characterizing the hematocrit test result of the blood sample in the sample container, information characterizing the clot test result of the blood sample in the sample container, information characterizing the liquid volume test result of the blood sample in the sample container, information characterizing the hemolysis test result of the blood sample in the sample container, information characterizing the jaundice test result of the blood sample in the sample container, and information characterizing the lipemia test result of the blood sample in the sample container.

23. The sample analysis device according to claim 21 or 22, characterized in that: The first interface includes: A first display area, wherein the first display area is used to display the first target image; a second display area, wherein the second display area is used to display the second target image; a third display area, the third display area being used to display at least one of information characterizing a hematocrit test result of the blood sample in the sample container, information characterizing a clot test result of the blood sample in the sample container, information characterizing a liquid volume test result of the blood sample in the sample container, information characterizing a hemolysis test result of the blood sample in the sample container, information characterizing a jaundice test result of the blood sample in the sample container, and information characterizing a lipemia test result of the blood sample in the sample container; Preferably, the first display area, the second display area and the third display area are distributed in the following manner: The first display area, the second display area and the third display area are arranged and distributed along a first direction; The first display area, the second display area and the third display area are arranged and distributed along a second direction; Two of the first display area, the second display area and the third display area are arranged and distributed along a first direction, and an area formed by the two together with another one is arranged and distributed along a second direction; Two of the first display area, the second display area and the third display area are arranged and distributed along the second direction, and the area formed by the two together with the other one is arranged and distributed along the first direction; The first direction and the second direction are perpendicular to each other.

24. A control method for a sample analysis device, characterized in that: The steps include: Controlling the display device to display a second interface; In response to a trigger instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device to display the first interface; The first interface displays a first target image obtained by photographing a sample container loaded with a blood sample and after the blood sample is centrifugally separated into an upper layer of liquid, a middle layer of liquid, and a lower layer of liquid by a camera device, and displays at least one of a second target image obtained by photographing the sample container by the camera device, information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; The intermediate layer liquid contains at least platelets and / or leukocytes; There is a boundary liquid surface or boundary liquid layer between the intermediate layer liquid and the upper layer liquid; The first target image at least includes an image showing the interface liquid surface or the interface liquid layer in a two-dimensional form and / or a three-dimensional form; The second target image at least includes an image showing the entire height of at least one side of the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the entire blood sample in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing the liquid surface of the upper liquid layer, the liquid surface of the middle liquid layer, and the liquid surface of the lower liquid layer in the sample container, or at least includes an image showing at least one side of the entire upper liquid layer, the entire middle liquid layer, and the entire lower liquid layer in the sample container in a two-dimensional and / or three-dimensional form, or at least includes an image showing at least one side of the bottom, middle part, and top of the sample container in a two-dimensional and / or three-dimensional form.

25. The control method of the sample analysis device according to claim 24, characterized in that: The controlling the display device to display the first interface includes: controlling the display device to display the first interface in a superimposed manner in a local area of ​​the second interface in a pop-up window; Alternatively, controlling the display device to display the first interface includes: controlling the display device to switch from displaying the second interface to displaying the first interface in a switching manner.

26. The control method of the sample analysis device according to claim 24 or 25, characterized in that: The first interface displays the first target image and the second target image, and displays at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; Preferably, the first interface displays the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

27. A control method for a sample analysis device, characterized in that: The steps include: Controlling the display device to display a second interface; In response to a trigger instruction formed by an operator viewing a blood sample in the second interface through at least one of screen touch, mouse control, keyboard control, and voice input, controlling the display device to display the first interface; The first interface displays a first target image obtained by photographing a sample container loaded with a blood sample and after the blood sample is centrifugally separated into an upper layer of liquid, a middle layer of liquid, and a lower layer of liquid by a camera device, and displays at least one of a second target image obtained by photographing the sample container by the camera device, information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; The first target image is used as a basis for at least one of the following: for an operator to determine whether the intermediate layer of liquid has a clot, for an operator to determine the degree of coagulation of the blood sample, and for an operator to review whether the information displayed in the first interface for characterizing the clot detection result of the blood sample in the sample container is accurate; The second target image is used as a basis for at least one of the following: for an operator to review whether the information in the first interface used to characterize the hematocrit test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the liquid volume test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the hemolysis test result of the blood sample in the sample container is accurate, for an operator to review whether the information in the first interface used to characterize the jaundice test result of the blood sample in the sample container is accurate, and for an operator to review whether the information in the first interface used to characterize the lipemia test result of the blood sample in the sample container is accurate.

28. The control method of the sample analysis device according to claim 27, characterized in that: The first interface displays the first target image and the second target image, and displays at least one of information used to characterize a hematocrit test result of the blood sample in the sample container, information used to characterize a clot test result of the blood sample in the sample container, information used to characterize a liquid volume test result of the blood sample in the sample container, information used to characterize a hemolysis test result of the blood sample in the sample container, information used to characterize a jaundice test result of the blood sample in the sample container, and information used to characterize a lipemia test result of the blood sample in the sample container; Preferably, the first interface displays the first target image, the second target image, information used to characterize the hematocrit test result of the blood sample in the sample container, information used to characterize the clot test result of the blood sample in the sample container, information used to characterize the liquid volume test result of the blood sample in the sample container, information used to characterize the hemolysis test result of the blood sample in the sample container, information used to characterize the jaundice test result of the blood sample in the sample container, and information used to characterize the lipemia test result of the blood sample in the sample container.

Images